INTRODUCTION
============

Ribosome-Inactivating Proteins (RIPs)
-------------------------------------

The term ribosome-inactivating protein (RIP) engenders a specific class of toxins, mostly of plant origin, which act predominantly on the ribosomal machinery *via* their *N*-glycosidase activity or polynucleotide adenosine glycosidase activity \[[@R1]\]. Although there is varying information about their mechanism of action, their enzymatic activity has drawn the most attention, especially relating to the anti-viral and anti-tumor effects \[[@R2]\]. In general, all RIPs are considered to be *N*-glycosidases, thus removing adenines from ribosomal RNA, and depurinating the conserved alpha-sarcin loop of the 28S ribosomal RNA (rRNA). This leads to the inhibition of protein synthesis, a vital process for cellular proliferation, and therefore leading to cell death \[[@R3]\].

The plant RIPs are further classified as type 1, 2 and in rare cases as type 3. Type 1 RIPs are characterized by the presence of only a toxic domain, whereas type 2 RIPs are the ones consisting of a toxin domain (A chain) together with a cell binding domain (B chain of lectin type). The B-chain facilitates its binding to the galactose residues on the cellular membrane, thus facilitating the cellular internalization. A further class of RIPs (type 3) has been proposed but the exact classification and occurrence are ambiguous. The literature description of type 3 RIP defines it as a protein which is evolutionarily related to a 60-kDa jasmonate-induced protein from barley, with RIP activity \[[@R4]\]. In total, there are nearly 250 RIPs that are scientifically described and the information pertinent to them was retrievable upon an extensive literature search. A summary of these RIPs with relevant literature reference and the botanical description is elaborated in Table **[1](#T1){ref-type="table"}**. The information provided includes the origin of the RIP, its type and the reported usage of this RIP as a targeted toxin.

While type I RIPs generally have lower toxicity, this is not predominantly because of their lack of enzymatic activity but contrastingly due to the missing B-chain making their cellular internalization cumbersome \[[@R5]\]. The missing cell binding domain is a blessing in disguise for molecular biologists, and has facilitated them to prepare fusion proteins or synthetic analogs of type 1 RIPs together with ligands that are able to facilitate their cellular internalization \[[@R6]\]. Moreover, in the recent decade, there has been a growing evidence that use of endosomal escape enhancers can lead to a significant augmentation of the efficacy of RIPs. This strategy has also paved a path for an improvement in the therapeutic utility of RIPs as targeted toxins or immunotoxins \[[@R5]\].

Endocytosis, Cytosolic Delivery and Enzymatic Action of RIPs
------------------------------------------------------------

The toxic potential of RIPs is determined by their ability to reach to the ribosomes, which are located within the cytosol. Thus, RIPs that are able to overcome cellular barriers end up exhibiting tremendous toxic potential. This overcoming of cellular barriers includes their internalization, which is generally facilitated by their B chain. Type 2 RIPs such as ricin from *Ricinus communis* L., abrin from *Abrus precatorius* L., or volkensin from *Adenia volkensii*Harms. \[[@R7]\] efficiently deliver their *N*-glycosidase domain (A chain) into the cytosol of intoxicated cells \[[@R8]\] which is facilitated by their B chains. The B chain serves as galactose/*N*-acetylgalactosamine binding domain (lectin) and is linked to the A chain *via* disulfide bonds.

After the binding with glycoproteins or glycolipids, which have numerous galactose residues on their surface, ricin is endocytosed *via* clathrin-dependent as well as clathrin-independent endocytosis and is thereafter delivered into the early endosomes. From there on it is transported to the Golgi-apparatus by retrograde transport and finally reaches the endoplasmic reticulum (ER). Within the ER the disulfide bonds are cleaved by thioredoxin reductases and disulfide isomerases \[[@R9],[@R10]\]. The enzymatically active A chain is released and partially unfolded during this process \[[@R11]\]. To facilitate its entry into the cytosol, the A chain exploits a mechanism, which is known as ER-associated degradation (ERAD). ERAD is a natural mechanism for maintaining the homeostasis of the ER \[[@R12]\]. Proteins that are misfolded and thus non-functional are designated for proteasome degradation within the cytosol. The transport of the partially unfolded A chain is mediated by the translocon Sec61p \[[@R13]\] and the ER degradation-enhancing α-mannosidase-like protein 1 \[[@R14]\]. One of the most important factors for the cytosolic delivery is the recognition of the A chain as a substrate for the ERAD system. This is achieved by disguising the A chain as a misfolded protein. After reaching the cytosol the partially unfolded A chain is fully refolded to regain the conformational integrity as an enzymatically active form. This is facilitated by the chaperons Hsc70 and Hsp90 \[[@R15]\]. Genetic interaction maps indicate the involvement of a number of different factors responsible for modulating the ricin trafficking \[[@R16]\]. The cytosolic delivery of the A chain marks the end of a highly efficient molecular strategy that ricin adopts in order to direct the catalytic domain to the ribosomes.

As mentioned before, a common feature of all the RIPs is their ability to depurinate the rRNA by releasing an adenine residue at their α-sarcin/ricin loop. This results in an irreversible inhibition of protein synthesis facilitated by the prevention of eukaryotic elongation factor binding \[[@R17]\]. According to the protein data bank (PDB), RIPs belong to a group of rRNA *N*-glycosidases (EC 3.2.2.22) that hydrolyze the *N*-glycosidic bonds at the position 4324 on the 28S rRNA. The bond between the N9 of adenine and the C1 of ribose is hydrolyzed by a concerted action of an arginine at position 180 (R180) and a glutaminic acid at position 177 (E177). E177 is stabilized at a cationic oxocarbenium ribose transition state and R180 is responsible for activating water. This facilitates the nucleophilic attack on the C1 of the oxocarbenium intermediate resulting in the release of adenine \[[@R18]\]. Mutants lacking E177 and R180 are also devoid of the *N*-glycosidase activity \[[@R19]\]. Recent studies suggest that the action of RIPs on ribosomes depends on the ribosomal stalk, which is a network of different proteins that recruit translational factors to the ribosomes \[[@R20]\]. After gaining access to their substrate, RIPs act as toxic agents. It is further hypothesized that only one internalized molecule is sufficient to kill one cell. From an evolutionary point of view, it has been suggested that the B chain of ricin was generated by a lateral gene transfer from a bacteria.

Contrasting to type 2 RIPs, type 1 RIPs are less toxic \[[@R21]\] and consist of only the A chain (*N*-glycosidase), which lacks any specific cell binding properties. The low cytotoxicity of type 1 RIPs is generally attributed to an inefficient endocytosis. However, based on some other reports \[[@R22]\] and our own experiments (Fig. **[1](#F1){ref-type="fig"}**), it is admissible that type 1 RIPs are effectively internalized. The major problem restricting their efficacy is the inefficient endosomal release.

The exact mechanism of the internalization of type 1 RIPs is not deciphered so far. Previous studies indicate towards a receptor-mediated endocytosis of type I RIPs by low density lipoprotein (LDL) receptors \[[@R23]-[@R26]\]. Contrastingly, some other results confirm a receptor independent endocytosis \[[@R22]\]. However, the exertion of toxic effects appears to be independent of the internalization mechanism. The toxicity determining factor is the ability of type 1 RIPs to cross the endo/lysosomal membrane. Since type 1 RIPs do not contain any transduction domains facilitating the endo/lyso-somal escape into the cytosol, they are less cytotoxic. Upon endocytosis, type 1 RIPs are delivered into the cellular compartments that are positive for lysobisphosphatidic acid (LBPA) (a specific eukaryotic phospholipid marker for late endosomes) and the lysosomal-associated membrane proteins LAMP1 and LAMP2 \[[@R22],[@R27]\]. Type I RIPs are thereafter degraded within the lysosomes \[[@R5]\].

Immunotoxins and Targeted Toxins
--------------------------------

Immunotoxins as per definition are conjugates of cell binding antibodies and the complete type 1/2 RIP or the A chain of a type 2 RIP \[[@R6]\]. In all the reported cases, the complete type 2 RIP has a very high cytotoxic effect when conjugated to the antibody. Nonetheless, there is an increased side effect due to the off-target binding of the B chain. To circumvent this, a lot of alternative strategies including but not limited to the use of high concentrations of free galactose or lactose as competitive binders have been tested. Another alternative in overcoming this problem has been the use of steric hindrance \[[@R28]\]. Coupling of an antibody or its fragment to the isolated A chain *via* disulfide linkage appears to be the most effective strategy. RIPs lack thiol groups for a disulfide linkage and it is necessary to synthetically introduce it. Alternatively, other linkages such as maleimide linkage have also been attempted but are not successful, mainly due to the inability of cellular enzymes to reductively cleave the bonds \[[@R29]\].

Another important term for the fusion proteins comprising of toxins is targeted toxin. It is a term which coherently finds usage in the literature to define a generic name for immunotoxins. In general, targeted toxins comprise of tumor specific ligands coupled to polypeptide toxins. They constitute a class of cancer therapeutics that leads to the death of cancer cells. They mainly act by the inactivation of cytosolic protein synthesis and induction of programmed cell death \[[@R3]\]. Immunotoxins are *per se*, restricted to an antibody or antibody fragment as the targeting moiety whereas, targeted toxins form a larger domain including the use of antibodies, small antibody fragments, growth factors, cytokines or small peptides as targeting moieties. Thus, immunotoxins form a smaller subset of targeted toxins as a classification in general.

These targeted toxins can either be prepared by chemical conjugation as described above, or they can be produced recombinantly as a fusion protein that is expressed in cells \[[@R6]\]. Within the past two decades, significant progress has been made towards proper identification of the appropriate cellular target for toxins with target specificity. Moreover, tremendous progress made in the field of genetic engineering and a better understanding of receptor physiology coupled with the single molecule tracking modality have led to an exponential growth in the scientific output as far as targeted toxins are concerned. This is further evidenced by an increased number of clinical trials which are being conducted on targeted toxins, with many of them in Phase 3 \[[@R30],[@R31]\].

Plant RIPs constitute a major portion of the therapies with targeted toxins, and although there is additional literature available on bacterial and human toxins, plant RIPs generate a lot of scientific interest. As listed in Table **[2](#T2){ref-type="table"}**, there are more than 450 targeted toxins described, which comprise of plant RIPs as a toxic moiety. Amongst various RIPs the leading toxin components are ricin A chain from *Ricinus communis*L., saporin from *Saponaria officinalis*L. and gelonin from *Gelonium multiflorum*A. Juss. A lot of different targeting ligands have been successfully coupled to these toxins and have demonstrated high specificity in *in vitro* and preclinical evaluations. The ligand, apart from providing selectivity, also helps in cellular internalization of the toxin. There are a number of aspects associated with the internalization and trafficking of toxins. When the toxins are transformed into targeted toxins, there are numerous critical elements deciding their fate *in vitro*and *in vivo*; these events are discussed in detail hereafter.

Antigen Selection and Efficiency of Internalization
---------------------------------------------------

The analysis of the expression pattern of tumor-associated surface antigens and the knowledge about their ability to promote or modulate the tumor growth are critical for the identification of novel targets for targeted anti-tumor therapies. For the development of monoclonal antibodies (mAbs) or targeted toxins, it is essential to determine, whether a particular surface antigen undergoes an accelerated internalization or not (Fig. **[2](#F2){ref-type="fig"}**). There is a variety of cancer-associated antigens that are being targeted by mAbs \[[@R32],[@R33]\]. For mAbs that mediate their efficacy in part by interaction with natural killer cells (NK) (antibody dependent cellular cytotoxicity, ADCC), it is important to select antigens, which do not undergo rapid down-regulation after binding. This is a feature contrasting the modality of targeted toxins, where it is desirable to select antigens that show enhanced endocytosis after ligand binding \[[@R34]\]. This facilitates a rapid delivery of the toxin into the cancer cells.

The receptor that is being addressed by the targeted toxin should be over-expressed on the tumor cell surface compared to the normal tissue. A considerable number of receptors \[[@R35]\] have been addressed to date, amongst them are the cytokine receptors \[[@R36]\], tumor necrosis factor receptor, growth factor receptors \[[@R37],[@R38]\] and cluster of differentiation CD22 \[[@R39]\], CD25 \[[@R40]\] and CD30 \[[@R41]\]. Contrasting to the numerous advantages listed above, a drawback of antibody-based targeted toxins is their limited ability to induce the effector functionalities of the naked antibodies. It is in fact a predominant basis for the concept of targeted toxins, wherein it is envisaged to outweigh the biological functionalities of the monoclonal antibodies by conjugating them to bacterial toxins such as *Pseudomonas* exotoxin from *Pseudomonas aeruginosa*\[[@R42]\] or plant toxins such as saporin from *Saponaria officinalis* L.

Release of Targeted Toxins into the Cytosol and their Lysosomal Degradation
---------------------------------------------------------------------------

Once internalized, the targeted toxin is delivered into early endosomes. Early endosomes are part of the endosomal transport system, which is an intracellular vesicular and tubular compartment surrounded by cytosol. Within early endosomes, endocytosed ligands (targeted toxins) are either designated for recycling \[[@R43],[@R44]\] or they are further transported into late endosomes, and finally lysosomes for degradation. Since targeted toxins exert their anti-tumoral efficacy only in the cytosol, it is a vital prerequisite for their efficacy that they are able to escape from the endosomal network into the cytosol. Targeted toxins fused to truncated variants of bacterial toxins such as diphtheria toxin (DT) from *Corynebacterium diphtheriae* utilize the native T-domain of DT to escape from early endosomes into the cytosol \[[@R42],[@R45],[@R46]\] while other targeted toxins employ a KDEL-like motive of their toxin moieties, which in turn facilitate their retrograde delivery into the ER and thereafter their transport to the cytosol \[[@R47]\]. However, plant-derived toxins such as saporin and gelonin or the A chain of the type 2 RIP ricin does not comprise of such translocation domains. It can be therefore anticipated that the cytosolic delivery of type 1 RIP-based targeted toxins is attenuated, compared to appropriate bacterial counterparts. However, comparative studies in this regard have not been undertaken so far.

Several strategies such as photochemical internalization \[[@R48]\], pore formation by listeriolysin O from *Listeria* *monocytogenes* \[[@R37]\], cell penetration by protein transduction domains \[[@R49]\], the use of lysosomotropic agents like chloroquine \[[@R50]\] or the use of triterpenoidal saponins from *Saponaria officinalis* L. and *Gypsophila paniculata* L. \[[@R51],[@R52]\] have been developed to facilitate the escape of targeted toxins from endosomal vesicles (a schematic overview on the obstacles for the cytosolic delivery of targeted toxins is depicted below above). All these methods prevent the lysosomal degradation of targeted toxins by mediating their endosomal escape into the cytosol. This results in a significant augmentation of the anti-tumoral efficacy of the targeted toxin.

Lysosomal degradation is one of the main issues in targeted tumor therapies \[[@R53]\]. It may be compensated by increasing the dosage of the targeted toxins, however, this does promote undesirable side effects. As mentioned above, lysosomal degradation can be outweighed by combination strategies that mediate the endosomal escape of targeted toxins. The generation of modified targeted toxins that are resistant against lysosomal degradation is a further attractive strategy to increase the efficacy of targeted toxins \[[@R54]\].

Advancement in the Use of RIPs as Therapeutic Agent
---------------------------------------------------

Initially, targeted toxins were constructed with native ricin and were tested *in vitro* in the presence of high concentrations of lactose which prevented the non-specific binding of ricin B-chain. Blocking of the oligosaccharide binding sites was used to prevent off-target ricin uptake and provided the possibility of applying the immunotoxins *in vivo*\[[@R55]\]. The separation of RTA and ricin B-chain by chemical reduction allowed conjugation of the antibody to the catalytic subunit, mainly through cross-linkers containing a disulfide bond. Despite the high yield and good stability of these targeted toxins, one of the main disadvantages for them was a heterogeneous composition \[[@R28]\]. Furthermore, it is well known that the glycosylated residues of RTA also facilitate non-specific uptake by macrophages. Therefore, in order to prevent the non-specific uptake, RTA was submitted to a process of deglycosylation before conjugation to the antibody and formation of the immunotoxin \[[@R56]\].

The advancement of recombinant tools has led to a rather ubiquitous utilization of these techniques for the production of toxins. For generating these targeted toxins, the gene portion encoding the antigen-binding fragments of an antibody (Fab or Fv) is generally coupled to the gene encoding for native catalytic domain. In another case it may be linked to the mutated version of the toxin. Once the construct is available it can be proliferated in any expression system such as bacteria, yeast or algae \[[@R57],[@R58]\]. The first generated recombinant immunotoxins were mostly formed using the single-chain variable fragments (scFvs), thereafter they were substituted by disulfide-stabilized Fvs (dsFvs). The scFvs have a peptide linker compared to the disulfide bridge in dsFvs which makes the conformation more stable.

Future Perspectives and Opinions on Targeted Toxins
---------------------------------------------------

Cancer is an expended burden in an ageing population. In the fight against this complex phenomenon, it would be a misjudgment to believe that one day a single strategy such as the use of targeted toxins will be able to defeat this disease. Thus, different complementary strategies are required to overcome all the hurdles that impede recovery. Surgical intervention, chemotherapy and radiation constitute the traditional troika of cancer therapies that are used as commonly for a wide variety of tumors.

Regrettably, in many cases this combination is not sufficient for a complete remission. Novel chemotherapeutics such as kinase inhibitors \[[@R59]\] and biological molecules such as antibodies \[[@R60]\] essentially improve the treatment of particular cancer entities. While kinase inhibitors are highly potent in suppressing cellular proliferation, antibodies are in particular characterized by their specificity for target cells. Targeted toxins combine the idea of tumor targeting and potent cytotoxicity in a single molecule. Thus, these molecules can be considered as an important addendum to complement the traditional troika. However, it must be stated that a promising therapeutic approach is finally characterized by its clinical success, but only a few targeted toxins have so far been approved by the Food and Drug Administration of the U.S., only one of them contains a protein-based toxin (denileukin diftitox) \[[@R61]\] and none of them is composed of a RIP. Nevertheless, targeted toxins containing RIPs are known from a number of clinical trials and a very large number of preclinical studies, indicating the great expected potential of this class of targeted toxins. Therefore, further research is needed to optimize current developments and to bring RIP-based anti-tumor drugs into the clinical routine. Although Moolten & Cooperband described as early as in 1970 the selective destruction of target cells by diphtheria toxin which was specifically linked to antibodies directed against specific antigens on the surface of tumor cells \[[@R62]\], the main obstacles for protein-based targeted toxins are still unsolved, which includes expensive production, unstable proteins and short biological half-life, immunogenicity and insufficient endosomal escape. Hundreds of research groups in the world are working on these problems, a substantial number of fruitful ideas have been published to date and the techniques to investigate and to manipulate such molecules are incredible compared to 1970 so that we can be confident that we must not wait further 40 years until targeted toxins will have their breakthrough.

Molecular Aspects and Mechanisms in Targeted Toxin Therapy
----------------------------------------------------------

Although the ultimate goal in a targeted tumor therapy is to kill the tumor cells, the modality of cell death must not be underestimated. Uncontrolled cell killing can result in colliquation, tyromatosis or coagulative necrosis, which may finally end up in causing life threatening or highly degenerative situation for the organism affected. On the contrary, apoptosis is a strictly controlled process for cell death. It can be induced by intracellular and/or extracellular signals resulting in systematic cell degradation with no damage of neighboring cells. While it is a commonly occurring process in numerous cells on a daily basis, it may be impaired in tumor cells \[[@R63]\].

A similar process for cellular degradation is autophagy which involves the activity of lysosomal machinery which digests different cellular organelles. It is a process dependent on internal or external cellular environment and may lead to either cell death or the promotion of cellular survival \[[@R64]\]. Apoptosis and autophagy are stimulated or suppressed by similar pathways. The way a cell responds to these pathways determines its survival or death (this has been extensively reviewed in \[[@R65]\]). In general, the toxin\'s primary target such as the ribosomal RNA for RIPs is not directly involved in necrosis, apoptosis or autophagy, but these targets are involved in vital cellular processes. It seems natural to assume that the interference with vital functions results in a series of events that finally trigger the apoptotic cascade \[[@R66]\], but this is not true for all cases. In case of saporin, the induction of apoptosis also occurs before protein synthesis inhibition takes place \[[@R67]\]. Apart from this, in numerous reports there is a discrepancy in the exact mechanism in case of similar parameters studied. While in some cell lines apoptosis was indicated the same could not be confirmed in others. This also implies that the cellular response to targeted toxins is a multifaceted complex mechanism. Therefore, the choice of the toxin is a factor that must be given optimal thought in the design of targeted toxins.

Drug Delivery Technologies Employed in Targeted Toxin Therapy
-------------------------------------------------------------

Carrier-based drug delivery systems have been widely exploited for the targeted delivery of toxins to the tumors. Commonly used drug targeting systems include nanoparticles, liposomes, virosomes, carbon nanotubes, microspheres, nanofibers amongst others \[[@R68]-[@R70]\]. A summary of the carrier and non-carrier based systems is shown in Fig. **[3](#F3){ref-type="fig"}**. Despite the difficulty in formulation and the need for a more thorough stability and interaction assessment, the use of a carrier-based approach has distinctive advantages. Carriers help in a more specific ligand attachment increasing the specificity for the delivery of cargo. Increasing the circulatory time as in case of liposomal nanocarriers was of advantage for the delivery of cholera toxin, and despite its utility for adjuvant effects, the strategy has potential for its application in tumor therapy as well. A classical utilization of the liposomal drug delivery system was the delivery of gelonin \[[@R71]\]. It was delivered to the cytoplasm of TLX5 lymphoma cells most effectively by phosphatidylserine vesicles. This formulation could also successfully inhibit the protein synthesis in XC cells (rat fibroblasts transformed by *Rous sarcoma* virus) and phytohemagglutinin-stimulated CBA mouse lymphocytes. Phosphatidylcholine could only show the transport facility after addition of cholesterol to the cells. Addition of mixed bovine brain gangliosides in the following order phosphatidylcholine/cholesterol/gang-liosides (5: 5: 1) escalated the effectiveness as well \[[@R71],[@R72]\]. Tumor targeted RIPs may take advantage of nanoparticulate drug delivery systems for intracellular targeting.

In the same context, a generation-4 polyamidoamine (PAMAM) dendrimer induced cellular uptake and intracellular release by facilitating the endocytic uptake of RIPs. The use of photochemical internalization (PCI) technology could increase the effectiveness of free RIPs and PAMAM-RIPs \[[@R73]\]. After PCI treatment, PAMAM-RIP facilitated internalization as well as nuclear entry. Albeit this being a negative outcome, the use of ER signaling could in turn be used to avoid this side effect and elicit a site specific response. The use of nanocarriers, liposomes, aptamers or dendrimeric structures may be helpful in the targeted delivery of the toxins. They surely facilitate the efficacy by either resulting in multivalence or providing a dual component delivery in a single system.

Efficacy Enhancers in Targeted Toxin Therapy
--------------------------------------------

In the past decade, a number of strategies have been attempted to circumvent the problems associated with immunogenicity, vascular leak syndrome and other off-target effects that are associated with targeted toxin therapy. Conventionally, the use of certain chemicals has been employed, which led to an elevation of the endosomal pH, thereby protecting the toxin from lysosomal enzyme degradation. Another strategy involved the use of pore forming agents (Fig. **[4](#F4){ref-type="fig"}**). Use of these components certainly helped in improving the efficacy but their proof in preclinical and clinical studies is still limited \[[@R74]-[@R78]\]. The details for other compounds including organic and inorganic substances, synthetic peptides and compounds of natural origin are detailed in Table **[3](#T3){ref-type="table"}**. In an interesting study, the anti-tumoral effects of anti-CD5 immunotoxins, which were constructed using a monoclonal antibody Fab fragment linked to native ricin A-chain or partially deglycosylated ricin A-chain, were examined in combination with the enhancer monensin conjugated to human serum albumin and injected intraperitoneally. In this case, 90% of the tumor cells were killed. This potentiating effect was observable even at a 5% monensin saturation level. The authors were able to successfully inhibit the effect by injecting the unconjugated antibody.

These results show that the therapeutic efficacy of immunotoxins can be very well improved by following a pre-defined and optimized therapeutic regime \[[@R79]\]. Monensin is one of the compounds with proven efficacy. In the recent past, an even higher synergy has been observed by the concomitant use of saponins and plant RIPs which is the basis for the next section.

Saponins in Targeted Toxin Therapy
----------------------------------

In our research group, we have been extensively working with the use of certain structurally specific triterpenoids *viz.*saponins. These compounds have shown tremendous potential in enhancing the effectiveness of targeted toxins; mainly plant type I RIPs saporin and dianthin (Fig. **[5](#F5){ref-type="fig"}**) \[[@R80],[@R81]\]. Saponins are generally classified as triterpenoidal or steroidal, based on the aglycone backbone. In general, the saponins have a sugar chain attached at either the C-3 or C-17 position (monodesmosidic saponins), or on both positions (bisdesmosidic saponins). In recent studies, the concomitant use of saponins from *Saponaria officinalis* L. and *Gypsophila paniculata* L. has been successful in synergistically enhancing the toxicity of saporin-EGF and dianthin-EGF \[[@R30]\]. Evaluation of the molecular mechanism revealed that the toxin was internalized *via* receptor mediated internalization, thereafter the saponins (which were used at a concentration far below their membrane pore forming concentrations) lead to an enhanced endosomal escape of the toxin, which in turn resulted in apoptosis. The efficacy of saponins to facilitate rapid cell death, when administered in unison with the targeted toxins was further confirmed in a real-time cytotoxicity evaluation. Cell death was observed as a fall of the impedance signal (representing the number of living cells) within the first 12 h of incubation of the toxin and the saponins, while the toxin alone requires a 10,000-fold higher concentration to induce cell death after a period of nearly 48 h of incubation. It is pertinent to mention here that the saponins were used at a concentration that has no effect on its own \[[@R74]-[@R76],[@R82]-[@R84]\].

The structural features of saponins that are highly desirable for their enhancing effects have been studied extensively. It is now established that bisdesmosidic triterpenoidal saponins, which have a gypsogenin or quillaic acid backbone with a glucuronic acid at C-3 position are most effective. Moreover, there are further specific structural and sugar chain requirements that lead to a relatively small number of saponins, which show effectiveness as synergistic enhancers. As already detailed, for exerting cytotoxicity, the release of toxin in the cytosol is a very important step. This process is however very feeble in case of internalized RIPs. Interestingly, Weng *et al.* demonstrated that saponins which are also biosynthesized by *Saponaria officinalis* L., can in a very specific manner facilitate the cytosolic transfer of toxin without affecting the plasma membrane integrity. This effect mainly takes place in late endosomes and lysosomes at a pH range between 4-5.5. A strong binding affinity for saponins with RIPs using surface plasmon resonance was also verified and the combination of the targeted toxin and saponin was validated for its effectiveness *in vivo* in a syngeneic mouse tumor model \[[@R85]\]. Although using saponins or for that matter any toxicity enhancer is a novel approach for improving the effectiveness of targeted toxins, there are certain limitations associated with this strategy more importantly from a clinical perspective. Any clinical application involving the use of multiple components is always a practical and a regulatory problem. This problem in case of saponins or other enhancers can only be circumvented by the use of a drug carrier system, which either encompasses the two components together or either of the two components form a part of the delivery matrix.
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OUTLOOK AND CONCLUSION
======================

The initial hope for immunotoxin-based therapy in the treatment of cancer was their perceived role as magic bullets functioning as a cure for solid tumors and blood borne malignancies \[[@R86]\]. Since the 1990s, clinical studies have clearly shown that the targeted toxin therapy works as a good supplement to the existing chemotherapeutic agents \[[@R87]\]. The combination of chemo- and immunotherapy is manifolds better than the effectiveness of either of them alone. This when accompanied with the combined use of enhancers would surely give the clinicians more advantage in treating the patients effectively. There are numerous facets to targeted toxin therapies and as summarized by Chandramohan *et al.* \[[@R88]\], the therapeutic success requires selective killing, absence of side effects or nonspecific toxicity, which should be further juxtaposed with successful delivery of the immunotoxin to tumor cells. Another important aspect for a clinical success is the designing of targeted toxin. This should be done in such a way that the production of anti-toxin antibodies is minimized in an ideal case. Most of the target receptors are ubiquitous and therefore, a bystander effect of the targeting strategy into normal tissues in most cases is unavoidable. It is in such instances that the use of a targeted toxin enhancer as described in Table **[3](#T3){ref-type="table"}** can certainly come to rescue. Since use of such strategy minimizes the dosage and therefore the accompanying side effects, the target specific cell killing is limited to the amount of toxin molecules available.

Another important aspect is the fact that most of the disseminated tumors are highly heterogeneous. This is further complicated by the variations in the receptor expression levels with progression of tumor into the different stages of growth \[[@R89]\]. It is in such cases that a "cocktail therapy" could be highly effective and beneficial \[[@R90]\]. In the past, the targeted toxins have shown limited success independently and it could be imagined that for a higher efficacy, a combination of a small drug with targeted toxins, administered concomitantly, may minimize the side effects of either of them, with an increased effectiveness. In addition, another strategy could be the use of a combination of two or more targeted toxins as shown by a joint application of anti-CD19 and anti-CD22 immunotoxins (Combotox) \[[@R91]\] or multiple receptor targeting by aptameric configurations of the toxins making them more specific to different receptor types, overexpressed in the tumor that is being targeted. The future for such an approach has tremendous potential with the recent advancement in high-throughput screening techniques and the growing importance of personalized medicine in case of tumor treatment.

Furthermore, development of bi-specific and tri-specific therapeutic antibodies would surely add to the armor of the clinicians handling targeted toxins in tumor therapy \[[@R92],[@R93]\]. It can be foreseen that a cargo of toxin, with multiple targeting ligands would be highly beneficial, not only in solid tumors but in case of disseminated and metastasized tumors as well. The future of targeted toxin therapies appears to be even more promising than within the previous decade; this is mainly ascribable to the tremendous advancements in the biotechnological tools and an unprecedented growth in the field of proteomics and genomics. The possibility of identification and procurement of inactive mutants and humanized or human toxins, which can be further modified as targeted toxins opens up new vistas for tumor treatment. Recombinant DNA and expression techniques have reached a stage where a mutated version once identified to be effective, can be expressed and obtained under good manufacturing conditions in a quick succession. Recent advancements in the antibody-based therapeutics include the generation of bi-specific antibodies and bio-mimicking antibodies, while retaining selectivity these antibodies reportedly have a better efficacy. This surely adds to the repertoire of molecular biologists for reducing the incubation time during the drug development process.
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![Three-dimensional depiction (z-stacks) of the endosomal network of ECV-304 cells loaded with Alexasaporin. ECV-304 cells were challenged for 3 h with 1 µM Alexa-Fluor 488 labeled saporin (type I RIP from Saponaria officinalis L.). Cells were co-incubated with pH rodo™ Red Dextran, a marker for endo/lysosomes and analyzed by confocal live cell imaging. Depicted is the endo/lysosomal network of one living ECV-304 cell. Green: Alexasaporin in celular vesicles, red: pHrodo™ Red Dextran in endosomes/lysosomes, yellow: co-localization of Alexasaporin and pHrodo™ Red Dextran in endosomes/lysosomes. The figure illustrates the fact that saporin is internalized and trapped in to the endosomal vesicles, thereafter it is degraded by the endo/lysosomal degradation.](CPD-20-6584_F1){#F1}

![An overview of the steps required for the recognition and internalization of the targeted toxin in the tumor cells. The critical step of target recognition determines the specificity, thereafter the celular machinery takes over and in the ideal case the toxin escapes from the endosomal membrane thus inactivating the ribosomes via N-glycosidase activity.](CPD-20-6584_F2){#F2}

![A classification chart summarizing the carrier or non-carrier based approaches for targeted tumor therapy. While targeted toxins fall under the noncarrier based approach, toxins may also be incorporated in inert carriers for better stability.](CPD-20-6584_F3){#F3}

![A mechanistic description of the three widely known phenomena for the endosomal escape of molecules. Past internalization the toxin release may be facilitated via membrane fusion, pore formation or proton sponge effect. Table 3 describes in detail all the compounds that facilitate these effects for improving the efficacy of targeted toxins.](CPD-20-6584_F4){#F4}

![A schematic description for the efficacy enhancement of certain plant type I RIPs using triterpenoidal saponins. 1. The toxin reaches the cell 2. Internalization and formation of endosomal vesicles, 3. Maturation of the endosomal vesicles along with the entrapped toxin, 4. Late endosome formation. 5. The toxin undergoes lysosomal degradation and thus the toxic effect is not elicited. 6. Particular saponins accumulates inside the endo/lysosomes by unknown mechanisms. The presence of saponins faciliates the endo/lysosomal release of the toxin in a pH dependent manner. 7. The toxin induces cell death inside the cytosol via apoptosis.](CPD-20-6584_F5){#F5}

###### 

RIPs isolated from different plants, their type and reported absolute molecular masses.

  Plant                                         RIP                                                                                          Type        Ma (kDa)    Immunotoxins   Ref.
  --------------------------------------------- -------------------------------------------------------------------------------------------- ----------- ----------- -------------- --------------
  *Abelmoschus esculentus*(L.) Moench           Abelesculin                                                                                  1           30                         \[94\]
  *Abrus precatorius*L.                         Abrin-a                                                                                      2           63          Yes            \[95\]
  *Abrus precatorius*L.                         Abrin-b                                                                                      2           67                         \[95\]
  *Abrus precatorius* L.                        Abrin-c                                                                                      2           63                         \[95\]
  *Abrus precatorius* L.                        Abrin-d                                                                                      2           67                         \[95\]
  *Abrus precatorius*L.                         Abrin-I                                                                                      2           64                         \[96\]
  *Abrus precatorius* L.                        Abrin-II                                                                                     2           63                         \[96\]
  *Abrus precatorius*L.                         Abrin-III                                                                                    2           63                         \[96\]
  *Abrus precatorius*L.                         APA-I                                                                                        2           130                        \[96\]
  *Abrus precatorius*L.                         APA-II                                                                                       2           128                        \[96\]
  *Abrus precatorius*L.                         *Abrus* agglutinin                                                                           2           67                         \[95\]
  *Abrus precatorius*L.                         *Abrus* agglutinin                                                                           2           134                        \[97\]
  *Abrus pulchellus*L.                          Pulchellin                                                                                   2           61.5 - 63                  \[98, 99\]
  *Adenia digitata*Burtt-Davy                   Modeccin                                                                                     2           57                         \[100\]
  *Adenia ellenbeckii*Harms.                    *Adenia ellenbeckii* RIP                                                                     1           30                         \[101\]
  *Adenia ellenbeckii*Harms.                    *Adenia ellenbeckii* RIP                                                                     2           60                         \[101\]
  *Adenia fruticosa*L. Burtt-Davy               *Adenia fruticosa* RIP                                                                       1           30                         \[101\]
  *Adenia goetzii*Burtt-Davy                    *Adenia goetzii* RIP                                                                         1           30                         \[101\]
  *Adenia goetzii*Burtt-Davy                    *Adenia goetzii* RIP                                                                         2           60                         \[101\]
  *Adenia keramanthus*Harms.                    *Adenia keramanthus* RIP                                                                     2           60 - 65                    \[101\]
  *Adenia lanceolata*Engl.                      *Adenia lanceolata* RIP                                                                      2           60                         \[101\]
  *Adenia lanceolata*Engl.                      Lanceolin                                                                                    2           61.2                       \[102\]
  *Adenia racemosa*W.J. de Wilde                *Adenia racemosa* RIP                                                                        1           30                         \[101\]
  *Adenia stenodactyla*Harms.                   *Adenia stenodactyla* RIP                                                                    2           60                         \[101\]
  *Adenia stenodactyla*Harms.                   Stenodactylin                                                                                2           63.1                       \[102\]
  *Adenia venenata* Forssk.                     *Adenia venenata* RIP                                                                        1           30                         \[101\]
  *Adenia venenata*Forssk.                      *Adenia venenata* RIP                                                                        2           60                         \[101\]
  *Adenia volkensii*Harms.                      Volkensin                                                                                    2           62                         \[103, 104\]
  *Agrostemma githago* L.                       Agrostin-2                                                                                   1           30.6                       \[105\]
  *Agrostemma githago* L.                       Agrostin-5                                                                                   1           29.5                       \[105\]
  *Agrostemma githago*L.                        Agrostin-6                                                                                   1           29.6                       \[105\]
  *Amaranthus caudatus*L.                       Amaranthin (*Amaranthus caudatus* agglutinin, ACA)                                           1           33 - 36                    \[106\]
  *Amaranthus tricolor*L.                       *Amaranthus tricolor* antiviral protein-27 (AAP-27)                                          1           27                         \[107\]
  *Amaranthus viridis*L.                        Amaranthin                                                                                   1           30                         \[108\]
  *Aralia elata*(Miq.) Seem                     Aralin (*Aralia elata* lectin)                                                               2           61.3                       \[109, 110\]
  *Asparagus officinalis*L.                     *Asparagus officinalis* RIP                                                                  1           32.5                       \[105\]
  *Asparagus officinalis*L.                     Asparin 1                                                                                    1           30.5                       \[111\]
  *Asparagus officinalis*L.                     Asparin 2                                                                                    1           29.8                       \[111\]
  *Basella rubra*Roxb.                          *Basella rubra* RIP 2a                                                                       1           30.6                       \[112\]
  *Basella rubra* Roxb.                         *Basella rubra* RIP 2b                                                                       1           31.2                       \[112\]
  *Basella rubra*Roxb.                          *Basella rubra* RIP 3                                                                        1           31.2                       \[112\]
  *Benincasa hispida*(Thunb.) Cogn.             Alpha-benincasin                                                                             Small RIP   11                         \[113\]
  *Benincasa hispida*(Thunb.) Cogn.             Beta-benincasin                                                                              Small RIP   10.6                       \[113\]
  *Benincasa hispida*(Thunb.) Cogn.             Hispin                                                                                       1           21                         \[114\]
  *Beta vulgaris*L.                             Betavulgin                                                                                   1           28                         \[115\]
  *Beta vulgaris* L.                            Beetin 27                                                                                    1           27                         \[116, 117\]
  *Beta vulgaris* L.                            Beetin 29                                                                                    1           29                         \[116, 117\]
  *Bougainvillea spectabilis*Willd.             Bouganin (*Bougainvillea spectabilis* RIP)                                                   1           26.2        Yes            \[112, 118\]
  *Bougainvillea xbuttiana*Willd.               *Bougainvillea xbuttiana* antiviral protein                                                  1           35.5                       \[119\]
  *Bryonia dioica*Jacq.                         Bryodin-L                                                                                    1           28.8                       \[111\]
  *Bryonia dioica*Jacq.                         Bryodin-1 (BD-1)                                                                             1           30          Yes            \[120\]
  *Bryonia dioica*Jacq.                         Bryodin-2 (BD-2)                                                                             1           27          Yes            \[121\]
  *Camellia sinensis*(L.) Kuntze                *Camellia sinensis* RIP (CS-RIP)                                                             2           63.6                       \[122\]
  *Celosia cristata*L*.*                        *Celosia cristata* antiviral protein 25 (CCP-25)                                             1           25                         \[123\]
  *Celosia cristata*L.                          *Celosia cristata* antiviral protein 27 (CCP-27)                                             1           27                         \[124\]
  *Charybdis maritima*L.                        Charybdin                                                                                    1           29                         \[125\]
  *Chenopodium album*L.                         *Chenopodium album* antiviral RIP (CAP30)                                                    1           30                         \[126, 127\]
  *Cinnamomum camphora*(L.) J. Presl.           Camphorin                                                                                    1           23                         \[128\]
  *Cinnamomum camphora*(L.) J. Presl.           Cinnamomin                                                                                   2           61                         \[128\]
  *Cinnamomum porrectum*L.                      Porrectin                                                                                    2           64.5                       \[129\]
  *Citrullus colocynthis*Schrad.                Colocin 1                                                                                    1           26.3        Yes            \[111\]
  *Citrullus colocynthis*Schrad.                Colocin 2                                                                                    1           26.3                       \[111\]
  *Clerodendrum inerme*(L.) Gaertn              CIP-29                                                                                       1           29                         \[130, 131\]
  *Clerodendrum inerme*(L.) Gaertn              CIP-34                                                                                       1           34                         \[130, 131\]
  *Croton tiglium*L.                            Crotin I                                                                                     1           ND                         \[132\]
  *Croton tiglium*L.                            Crotin II                                                                                    1           30.2                       \[132\]
  *Cucumis figarei*Naud.                        *Cucumis figarei* RIP (CF-RIP)                                                               1           31.8                       \[133\]
  *Cucumis melo*L.                              Melonin                                                                                      1           23.5                       \[134, 135\]
  *Cucurbita foetidissima*Kunth.                Foetidissimin                                                                                2           63                         \[136\]
  *Cucurbita foetidissima*Kunth.                Foetidissimin II                                                                             2           61                         \[137\]
  *Cucurbita maxima*L.                          Cucurmoschin                                                                                 Small RIP   8                          \[138\]
  *Cucurbita moschata*Duchesne ex Poir.         Alpha-moschin                                                                                Small RIP   12                         \[139\]
  *Cucurbita moschata*Duchesne ex Poir.         Beta-moschin                                                                                 Small RIP   12                         \[139\]
  *Cucurbita moschata*Duchesne ex Poir.         Moschatin                                                                                    1           29          Yes            \[140\]
  *Cucurbita moschata*Duchesne ex Poir.         Cucurmosin (CUS)                                                                             1           27                         \[141, 142\]
  *Cucurbita moschata*Duchesne ex Poir.         Cucurmosin 2                                                                                 1           27.2                       \[143\]
  *Cucurbita moschata*Duchesne ex Poir.         *Cucurbita moschata* RIP                                                                     1           30.7                       \[144\]
  *Cucurbita pepo*L.                            Pepocin                                                                                      1           26                         \[145\]
  *Cucurbita texana*(Scheele) A. Gray           Texanin                                                                                      1           29.7                       \[137\]
  *Dianthus barbatus*L.                         Dianthin-29                                                                                  1           29                         \[146\]
  *Dianthus caryophyllus*L.                     Dianthin-30                                                                                  1           29.5        Yes            \[147, 148\]
  *Dianthus caryophyllus*L.                     Dianthin-32                                                                                  1           31.7        Yes            \[147, 148\]
  *Dianthus sinensis*L.                         *Dianthus sinensis* RIP (DsRIP)                                                              1           33.3                       \[149\]
  *Eranthis hyemalis*Salisb.                    *Eranthis hyemalis* lectin (EHL)                                                             2           62                         \[150, 151\]
  *Gelonium multiflorum*A. Juss.                Gelonin (GAP31)                                                                              1           31          Yes            \[152, 153\]
  *Gynostemma pentaphyllum*(Thunb.) Makino      Gynostemmin                                                                                  1           27                         \[144, 154\]
  *Gypsohila elegans*Bieb.                      Gypsophilin                                                                                  1           28                         \[155\]
  *Hordeum vulgare*L.                           Barley translation inhibitor (barley toxin I, BRIP)                                          1           31          Yes            \[156\]
  *Hordeum vulgare*L.                           Barley toxin II                                                                              1           30          Yes            \[157\]
  *Hordeum vulgare*L.                           Barley toxin III                                                                             1           30                         \[157\]
  *Hordeum vulgare*L.                           JIP60 (60 kDa jasmonate-induced protein)                                                     3           60                         \[158\]
  *Hura crepitans*L.                            *Hura crepitans* RIP                                                                         1           28                         \[105\]
  *Iris hollandica*L.                           *Iris* agglutinin b (IRAb)                                                                   2           65                         \[159\]
  *Iris hollandica*L.                           *Iris* agglutinin r (IRAr)                                                                   2           65                         \[159\]
  *Iris hollandica*L.                           *Iris* RIP A1 (IRIP A1)                                                                      1           30.9                       \[160\]
  *Iris hollandica*L.                           *Iris* RIP A2 (IRIP A2)                                                                      1           31                         \[160\]
  *Iris hollandica*L.                           *Iris* RIP A3 (IRIP A3)                                                                      1           30.9                       \[160\]
  *Jatropha curcas*L.                           Curcin                                                                                       1           28.2        Yes            \[161, 162\]
  *Jatropha curcas*L.                           Jc-SCRIP                                                                                     1           38.9                       \[163\]
  *Lagenaria siceraria*Molina.                  Lagenin                                                                                      1           20                         \[164\]
  *Luffa acutangula*Roxb.                       Luffaculin-1                                                                                 1           28                         \[165\]
  *Luffa acutangula*Roxb.                       Luffaculin-2                                                                                 1           28                         \[165\]
  *Luffa acutangula*Roxb.                       Luffangulin                                                                                  Small RIP   6.5                        \[166\]
  *Luffa aegyptiaca*Mill.                       Luffin-c                                                                                     1           ND                         \[167\]
  *Luffa aegyptiaca*Mill.                       *Luffa* ribosomal inhibitory protein (LRIP)                                                  1           30          Yes            \[168\]
  *Luffa cylindrica*Mill.                       Luffacylin                                                                                   Small RIP   7.8                        \[169\]
  *Luffa cylindrica*Mill.                       Luffin-A (alpha-luffin)                                                                      1           27          Yes            \[170, 171\]
  *Luffa cylindrica*Mill.                       Luffin-B (beta-luffin)                                                                       1           28          Yes            \[170\]
  *Luffa cylindrica*Mill.                       Luffin-P1                                                                                    Small RIP   5.2         Yes            \[172\]
  *Luffa cylindrica*Mill.                       Luffin-S                                                                                     Small RIP   10                         \[173\]
  *Lychnis chalcedonica*L.                      Lychnin                                                                                      1           26.1                       \[111, 174\]
  *Malania oleifera*Chun & S.K. Lee             Malanin                                                                                      2           61.9                       \[175\]
  *Manihot palmate* Mill.                       Mapalmin                                                                                     1           32.3                       \[111\]
  *Manihot utilissima*Mill.                     Manutin                                                                                      1           30.7                       \[176\]
  *Marah oreganus (Torr. ex S. Wats.) Howell*   MOR-I (*Marah* *oreganus* RIP-I)                                                             1           28                         \[177\]
  *Marah oreganus (Torr. ex S. Wats.) Howell*   MOR-II (*Marah oreganus* RIP-II)                                                             1           27.6                       \[177\]
  *Mesembryanthemum crystallinum*L.             RIP1                                                                                         1           32.7                       \[178\]
  *Mirabilis expansa*Standl.                    ME1                                                                                          1           27                         \[179\]
  *Mirabilis expansa* Standl.                   ME2                                                                                          1           27.5                       \[179\]
  *Mirabilis jalapa*L.                          *Mirabilis* antiviral protein (MAP)                                                          1           27.8                       \[180\]
  *Mirabilis jalapa*L.                          MAP-2                                                                                        1           30.4                       \[180\]
  *Mirabilis jalapa*L.                          MAP-3                                                                                        1           29.7                       \[180\]
  *Mirabilis jalapa*L.                          MAP-4                                                                                        1           29.3                       \[180\]
  *Momordica balsamina*L.                       *Momordica balsamina* RIP-1 (MbRIP-1)                                                        1           30                         \[181\]
  *Momordica balsamina*L.                       Momordin II                                                                                  1           32                         \[182\]
  *Momordica balsamina*L.                       Balsamin                                                                                     1           28                         \[183\]
  *Momordica charantia*L.                       Momordin (*Momordica charantia* inhibitor, momordin-a)                                       1           23          Yes            \[184\]
  *Momordica charantia*L.                       Alpha-momorcharin (alpha-MMc)                                                                1           29                         \[185, 186\]
  *Momordica charantia* L.                      Beta-momorcharin (beta-MMc)                                                                  1           28                         \[187, 188\]
  *Momordica charantia* L.                      Gamma-momorcharin                                                                            Small RIP   11.5                       \[189\]
  *Momordica charantia* L.                      Delta-momorcharin                                                                            1           30                         \[190\]
  *Momordica charantia* L.                      Epsilon-momorcharin                                                                          1           24                         \[190\]
  *Momordica charantia* L.                      *Momordica charantia* lectin (MCL)                                                           2           130                        \[122\]
  *Momordica charantia* L.                      Charantin                                                                                    Small RIP   9.7                        \[191\]
  *Momordica charantia* L.                      Momordin I (*Momordica charanthia* inhibitor)                                                1           31          Yes            \[147, 192\]
  *Momordica cochinchinensis*Spreng             Momorcochin-S                                                                                1           30          Yes            \[193\]
  *Momordica cochinchinensis*Spreng             Momorcochin                                                                                  1           32          Yes            \[194\]
  *Momordica cochinchinensis*Spreng             Cochinin B                                                                                   1           28                         \[195, 196\]
  *Momordica grosvenorii* Swingle               Momorgrosvin                                                                                 1           27.7                       \[197\]
  *Muscari armeniacum*Baker.                    Musarmin-1 (MU-1)                                                                            1           28.7                       \[198\]
  *Muscari armeniacum*Baker.                    Musarmin-2 (MU-2)                                                                            1           30                         \[198\]
  *Muscari armeniacum* Baker.                   Musarmin-3 (MU-3)                                                                            1           27.6                       \[198\]
  *Nicotiana tabacum*L.                         Tobacco RIP (TRIP)                                                                           1           26                         \[199\]
  *Nicotiana tabacum*L*.*                       CIP31                                                                                        1           31                         \[200\]
  *Oryza sativa*L.                              *Oryza sativa* RIP                                                                           1           33                         \[201\]
  *Oryza sativa*L.                              *Oryza sativa* cultivar Kazemi RIP                                                           1           29                         \[202\]
  *Panax ginseng*L.                             Panaxagin                                                                                    RIP-like    52                         \[203\]
  *Panax quinquefolium*L.                       Quinqueginsin                                                                                RIP-like    53                         \[204\]
  *Petrocoptis glaucifolia*(Lag.) Boiss.        Petroglaucin-1                                                                               1           26.7                       \[205\]
  *Petrocoptis glaucifolia*(Lag.) Boiss.        Petroglaucin-2                                                                               1           27.5                       \[206\]
  *Petrocoptis grandiflora*Rothm.               Petrograndin                                                                                 1           28.6                       \[205\]
  *Phoradendron californicum* Nutt.             *Phoradendron californicum* lectin (PCL)                                                     2           69                         \[207\]
  *Phytolacca americana*L.                      PAP (pokeweed antiviral protein, *Phytolacca* antiviral protein)                             1           29          Yes            \[208, 209\]
  *Phytolacca americana*L.                      PAP II (pokeweed antiviral protein II)                                                       1           30          Yes            \[209\]
  *Phytolacca americana*L.                      PAP III (pokeweed antiviral protein III)                                                     1           30                         \[210, 211\]
  *Phytolacca americana*L.                      PAP-S                                                                                        1           30          Yes            \[212\]
  *Phytolacca americana*L.                      PAP-C                                                                                        1           29                         \[213\]
  *Phytolacca americana*L.                      PAP-R                                                                                        1           29.8                       \[111\]
  *Phytolacca americana*L.                      PAP-H                                                                                        1           29.5                       \[214\]
  *Phytolacca dioica*L.                         PD-S1 (*Phytolacca dioica* RIP 1)                                                            1           30                         \[215\]
  *Phytolacca dioica*L.                         PD-S2 (*Phytolacca dioica* RIP 2)                                                            1           29.6        Yes            \[215, 216\]
  *Phytolacca dioica* L.                        PD-S3 (*Phytolacca dioica* RIP 3)                                                            1           30                         \[215\]
  *Phytolacca dioica* L.                        PD-L1                                                                                        1           32.7                       \[217, 218\]
  *Phytolacca dioica* L.                        PD-L2                                                                                        1           31.5                       \[217, 218\]
  *Phytolacca dioica* L.                        PD-L3                                                                                        1           30.4                       \[217, 218\]
  *Phytolacca dioica* L.                        PD-L4                                                                                        1           29.2                       \[217, 218\]
  *Phytolacca dioica* L.                        Dioicin 1                                                                                    1           30                         \[219, 220\]
  *Phytolacca dioica* L.                        Dioicin 2                                                                                    1           29.9                       \[219, 220\]
  *Phytolacca dodecandra*L'Herrit               Dodecandrin                                                                                  1           29                         \[221\]
  *Phytolacca heterotepala*H. Walter            Heterotepalin-4 (Mexican pokeweed RIP-4, *Phytolacca heterotepala* anti-viral protein PAP)   1           29.3                       \[222\]
  *Phytolacca heterotepala*H. Walter            Heterotepalin-5b (Mexican pokeweed RIP-5b)                                                   1           30.5                       \[222\]
  *Phytolacca insularis*Nakai                   *Phytolacca insularis* antiviral protein (PIP, insularin)                                    1           35                         \[223\]
  *Phytolacca insularis*Nakai                   *Phytolacca insularis* antiviral protein 2 (PIP2)                                            1           35.7                       \[224\]
  *Pisum sativum*L.                             Alpha-pisavin                                                                                1           20.5                       \[225\]
  *Pisum sativum*L.                             Beta-pisavin                                                                                 1           18.7                       \[225\]
  *Pisum sativum*L.                             Sativin                                                                                      1           38                         \[226\]
  *Polygonatum multiflorum*Kunth.               *Polygonatum multiflorum* RIP monomer (PMRIPm)                                               2           60                         \[227\]
  *Polygonatum multiflorum* Kunth.              *Polygonatum multiflorum* RIP tetramer (PMRIPt)                                              2           240                        \[227\]
  *Ricinus communis*L.                          Ricin                                                                                        2           62          Yes            \[228\]
  *Ricinus communis*L.                          Ricin 1                                                                                      2           64                         \[229\]
  *Ricinus communis*L.                          Ricin 2                                                                                      2           67                         \[229\]
  *Ricinus communis*L.                          Ricin 3                                                                                      2           66                         \[229\]
  *Ricinus communis*L.                          Ricin D                                                                                      2           60                         \[230\]
  *Ricinus communis*L.                          Ricin E                                                                                      2           60                         \[231\]
  *Ricinus communis*L.                          *Ricinus* agglutinin (RCA120)                                                                2           120                        \[97\]
  *Ricinus communis*L.                          *Ricinus* agglutinin 1 (RCA1)                                                                2           134                        \[229\]
  *Ricinus communis*L.                          *Ricinus* agglutinin 2 (RCA2)                                                                2           140                        \[229\]
  *Ricinus sanguineus*Hort. ex Groenland        Ricin R2                                                                                     2           63.1                       \[232\]
  *Ricinus sanguineus*Hort. ex Groenland        Ricin R11                                                                                    2           57.8                       \[232\]
  *Ricinus sanguineus*Hort. ex Groenland        Ricin R12                                                                                    2           62.2                       \[232\]
  *Ricinus sanguineus*Hort. ex Groenland        *Ricinus sanguineus* agglutinin                                                              2           120                        \[233\]
  *Sambucus ebulus* L.                          Ebulin r                                                                                     2           56                         \[234\]
  *Sambucus ebulus* L.                          Ebulin I (ebulin 1)                                                                          2           56          Yes            \[235\]
  *Sambucus ebulus* L.                          Alpha-ebulitin                                                                               1           32                         \[236\]
  *Sambucus ebulus* L.                          Beta-ebulitin                                                                                1           29                         \[236\]
  *Sambucus ebulus* L.                          Gamma-ebulitin                                                                               1           29                         \[236\]
  *Sambucus nigra*L.                            Basic nigrin b                                                                               2           63.5                       \[237\]
  *Sambucus nigra*L.                            Nigrin b                                                                                     2           58          Yes            \[238\]
  *Sambucus nigra*L.                            Nigritin f1                                                                                  1           24.1                       \[239\]
  *Sambucus nigra*L.                            Nigritin f2                                                                                  1           23.6                       \[239\]
  *Sambucus nigra*L.                            *Sambucus nigra* agglutinin I (SNAI)                                                         2           140                        \[240\]
  *Sambucus nigra*L.                            SNLRP                                                                                        2           60 - 62                    \[241\]
  *Sambucus racemosa*L.                         Basic racemosin b                                                                            2           58                         \[242\]
  *Sambucus sieboldiana*L.                      Sieboldin-b                                                                                  2           59.4                       \[243\]
  *Saponaria ocymoides*L.                       Ocymoidine                                                                                   1           30.2        Yes            \[244\]
  *Saponaria officinalis*L.                     Saporin-6                                                                                    1           29.5        Yes            \[105, 245\]
  *Saponaria officinalis*L.                     Saporin-9                                                                                    1           29.5                       \[105\]
  *Saponaria officinalis*L.                     Saporin-L1                                                                                   1           31.6        Yes            \[246\]
  *Saponaria officinalis*L.                     Saporin-L2                                                                                   1           31.6                       \[246\]
  *Saponaria officinalis*L.                     Saporin-R1                                                                                   1           30.2                       \[246\]
  *Saponaria officinalis*L.                     Saporin-R2                                                                                   1           30.9                       \[246\]
  *Saponaria officinalis*L.                     Saporin-R3                                                                                   1           30.9                       \[246\]
  *Saponaria officinalis*L.                     Saporin-S5                                                                                   1           30.9                       \[246\]
  *Saponaria officinalis*L.                     Saporin-S6                                                                                   1           31.6        Yes            \[246\]
  *Saponaria officinalis*L.                     Saporin-S8                                                                                   1           29.5                       \[246\]
  *Saponaria officinalis*L.                     Saporin-S9                                                                                   1           29.5                       \[246\]
  *Secale cereale*L.                            *Secale cereale* RIP                                                                         1           31                         \[247\]
  *Sechium edule*(Jacq.) Sw.                    Sechiumin                                                                                    1           27                         \[248\]
  *Spinacia oleracea*L.                         *Spinacia oleracea* RIP1 (SoRIP1, BP31)                                                      1           31                         \[249\]
  *Spinacia oleracea*L.                         *Spinacia oleracea* RIP2 (SoRIP2)                                                            1           29                         \[249\]
  *Stellaria aquatica*Scop.                     Stellarin                                                                                    1           ND                         \[250\]
  *Stellaria media*(L.) Vill.                   RIP Q3                                                                                       1           28.2                       \[251\]
  *Trichosanthes anguina* L.                    Trichoanguin                                                                                 1           35                         \[252\]
  *Trichosanthes cucumerina*Wall.               *Trichosanthes cucumerina* seed lectin (TCSL)                                                RIP-like    69                         \[253\]
  *Trichosanthes cucumeroides*Maxim.            Beta-trichosanthin                                                                           1           28                         \[254\]
  *Trichosanthes dioica*Roxb.                   *Trichosanthes dioica* seed lectin (TDSL)                                                    RIP-like    55                         \[255\]
  *Trichosanthes kirilowii*Maxim.               Alpha-kirilowin                                                                              1           28.8                       \[256\]
  *Trichosanthes kirilowii*Maxim.               Beta-kirilowin                                                                               1           27.5                       \[257\]
  *Trichosanthes kirilowii*Maxim.               Trichosanthin (TCS)                                                                          1           25 - 26     Yes            \[258\]
  *Trichosanthes kirilowii*Maxim.               TAP-29 (*Trichosanthes* anti-HIV protein 29 kDa)                                             1           29                         \[259\]
  *Trichosanthes kirilowii*Maxim.               Trichobitacin                                                                                1           27.2                       \[260, 261\]
  *Trichosanthes kirilowii*Maxim.               S-Trichokirin                                                                                Small RIP   8                          \[262\]
  *Trichosanthes kirilowii*Maxim.               Trichokirin-S1                                                                               Small RIP   11.4                       \[263\]
  *Trichosanthes kirilowii*Maxim.               Alpha-trichosanthin                                                                          1           31.7                       \[264\]
  *Trichosanthes kirilowii*Maxim.               Karasurin-A                                                                                  1           27.1                       \[265, 266\]
  *Trichosanthes kirilowii*Maxim.               Karasurin-B                                                                                  1           27.2                       \[267\]
  *Trichosanthes kirilowii*Maxim.               Karasurin-C                                                                                  1           27.4                       \[267\]
  *Trichosanthes kirilowii*Maxim.               Trichosanthrip                                                                               Small RIP   11                         \[268\]
  *Trichosanthes kirilowii*Maxim.               Trichomislin                                                                                 1           27.2                       \[269\]
  *Trichosanthes kirilowii*Maxim.               Trichokirin                                                                                  1           27          Yes            \[270\]
  *Trichosanthes lepiniate*Maxim.               Trichomaglin                                                                                 1           24.7                       \[271\]
  *Trichosanthes sp. Bac Kan 8-98*              Trichobakin                                                                                  1           27                         \[272\]
  *Triticum aestivum*L.                         Tritin                                                                                       1           30                         \[273\]
  *Vaccaria pyramidata*Medik.                   Pyramidatine                                                                                 1           28          Yes            \[244\]
  *Viscum album*L.                              Viscumin (mistletoe lectin I)                                                                2           60          Yes            \[274\]
  *Viscum articulatum*Burm. F.                  Articulatin-D                                                                                2           66                         \[275\]
  *Ximenia americana*L.                         Riproximin                                                                                   2           63                         \[276\]
  *Zea mays*L.                                  Maize seed RIP (b-32, corn RIP)                                                              1           32.4                       \[277\]
  *Zea mais*L.                                  Maize proRIP                                                                                 3           34                         \[278\]

###### 

A comprehensive list of all the targeted toxins based on plant RIPs investigated so far.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Toxin                                       Immunotoxin                                                  Ligand                                                              Target antigen                                                            Tumor/Disease                                                                                                                                                      *In* *vitro*   *In* *vivo*   Clinical trial status   Ref.
  ------------------------------------------- ------------------------------------------------------------ ------------------------------------------------------------------- ------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------- ------------- ----------------------- -------------------
  Abrin                                       Abrin-9.2.27                                                 mAb (9.2.27)                                                        Melanoma-associated antigen (p250)                                        Melanoma                                                                                                                                                           Yes            Yes                                   \[279, 280\]

  Abrin                                       Abrin-NR-ML-05                                               mAb (NR-ML-05)                                                      Melanoma-associated antigen (p250)                                        Melanoma                                                                                                                                                           Yes                                                  \[281\]

  Abrin A-chain                               Fib 75-abrin A chain                                         mAb (LICR-LOND Fib 75)                                              Bladder cancer antigen                                                    EJ bladder cancer                                                                                                                                                  Yes            Yes                                   \[282-284\]

  Abrin A-chain                               C27-Abrin A chain (MAAC)                                     mAb (C27)                                                           Carcinoembryonic antigen (CEA)                                            Colorectal cancer                                                                                                                                                  Yes            Yes                                   \[285\]

  Abrin A-chain                               Anti-Thy 1.1-Abrin A-chain                                   mAb (anti-Thy 1.1) (OX7)                                            CD90.1 (Thy 1.1)                                                          AKR-A lymphoma                                                                                                                                                     Yes            Yes                                   \[286\]

  Abrin A-chain                               Anti-Hepatoma-associated Antigen-Abrin A-chain               mAb (anti-hepatoma-associated antigen L10 190 kDa glycoprotein)     Hepatoma-associated antigen L10 190 kDa glycoprotein                      Hepatocarcinoma                                                                                                                                                    Yes                                                  \[287\]

  Abrin A-chain                               ITA                                                          IgG (anti-Trypanosoma cruzi surface antigens)                       Trypanosoma cruzi surface antigens                                        *Trypanosoma cruzi*                                                                                                                                                Yes                                                  \[288\]

  Abrin A-chain                               F1G4-rABRa-A                                                 mAb (F1G4)                                                          Gonadotropin releasing hormone (GnRH) receptor                            Breast cancer, hepatocarcinoma                                                                                                                                     Yes                                                  \[289\]

  Abrin A-chain                               SWA11-SPDB-abrin A                                           mAb (SWA11)                                                         CD24                                                                      SCLC                                                                                                                                                               Yes                                                  \[290\]

  Abrin A-chain                               ABRaA-VEGF121                                                VEGF121                                                             VEGFR-2                                                                   Melanoma                                                                                                                                                           Yes            Yes                                   \[291\]

  Abrin variant                               Tfn-abrin variant                                            Human diferric transferrin (Tfn)                                    TfR                                                                       Glioblastoma multiforme, melanoma                                                                                                                                  Yes                                                  \[292\]

  Barley toxin I                              H65-MM-rBRIP                                                 mAb (H65)                                                           CD5                                                                       ALL                                                                                                                                                                Yes                                                  \[293\]

  Barley toxin I                              4A2-MM-rBRIP                                                 mAb (4A2)                                                           CD7                                                                       ALL                                                                                                                                                                Yes                                                  \[293\]

  Barley toxin I                              Anti-melanoma-BRIP                                           mAb (anti-melanoma)                                                 Melanoma antigen                                                          Melanoma                                                                                                                                                           Yes                                                  \[294\]

  Barley toxin II                             5E9C11-Barley toxin II                                       mAb (HB21) (5E9)                                                    TfR                                                                       Colon cancer                                                                                                                                                       Yes                                                  \[157\]

  Bouganin                                    Anti-CD80/bouganin (M24-bouganin)                            mAb (M24)                                                           CD80                                                                      Hodgkin\'s lymphoma, Burkitt\'s lymphoma                                                                                                                           Yes                                                  \[295\]

  Bouganin                                    Anti-CD86/bouganin                                           mAb (anti-CD86) (1G10)                                              CD86                                                                      Hodgkin\'s lymphoma, Burkitt\'s lymphoma                                                                                                                           Yes                                                  \[295\]

  deBouganin                                  VB6-845                                                      Fab (4D5MOCB)                                                       EpCAM                                                                     Solid tumors of epithelial origin                                                                                                                                  Yes            Yes           Phase I                 \[296, 297\]

  Bryodin-1                                   OX7-bryodin                                                  mAb (anti-Thy 1.1) (OX7)                                            CD90.1 (Thy 1.1)                                                          AKR-A lymphoma                                                                                                                                                     Yes                                                  \[298\]

  Bryodin-1                                   BD1-G28-5 sFv                                                scFv (G28-5)                                                        CD40                                                                      B-cell non-Hodgkin's lymphoma, multiple myeloma                                                                                                                    Yes                                                  \[299, 300\]

  Bryodin-1                                   chiBR96-BD-1                                                 scFv (BR96)                                                         Ley antigen                                                               Breast cancer                                                                                                                                                      Yes                                                  \[301\]

  Bryodin-1                                   Anti-epithelial antigen-bryodin                              mAb (anti-epithelial antigen)                                       Epithelial antigen                                                        Colon cancer, epidermoid carcinoma                                                                                                                                 Yes                                                  \[302\]

  Gelonin                                     Lym-I-gelonin                                                mAb (Lym-1)                                                         HLA-DR                                                                    Burkitt's lymphoma cells                                                                                                                                           Yes                                                  \[318\]

  Gelonin                                     B4G7-gelonin                                                 mAb (B4G7)                                                          EGFR                                                                      Lung cancer                                                                                                                                                        Yes            Yes                                   \[319\]

  Gelonin                                     80G-gelonin                                                  mAb (80G)                                                           Alpha-fetoprotein                                                         Hepatoma                                                                                                                                                           Yes            Yes                                   \[320\]

  Gelonin                                     ZME-gelonin                                                  mAb (ZME-018)                                                       Proteoglycan, p250                                                        Melanoma                                                                                                                                                           Yes            Yes                                   \[321, 322\]

  Gelonin                                     Gelonin-9.2.27                                               mAb (9.2.27)                                                        Melanoma-associated antigen (p250)                                        Melanoma                                                                                                                                                           Yes            Yes                                   \[280\]

  Gelonin                                     AChR-gelonin                                                 AChR (nicotinic acetylcholine receptor)                             IgG (anti-AChR)                                                           Experimental autoimmune myasthenia gravis (EAMG)                                                                                                                   Yes            Yes                                   \[323\]

  Gelonin                                     38.13-gelonin                                                mAb (38.13)                                                         TH ceramide (Pk antigen)                                                  Burkitt\'s lymphoma                                                                                                                                                Yes                                                  \[324\]

  Gelonin                                     Anti-T11-gelonin                                             mAb (OKT11)                                                         CD2                                                                       T cells                                                                                                                                                            Yes            Yes                                   \[325, 326\]

  Gelonin                                     Tf-gelonin                                                   Transferrin                                                         TfR                                                                       Malaria (*Plasmodium falciparum*)                                                                                                                                  Yes                                                  \[327\]

  Gelonin                                     AR3-gelonin                                                  mAb (AR3)                                                           CAR-3                                                                     Gastric cancer                                                                                                                                                     Yes            Yes                                   \[328\]

  Gelonin                                     15A8-gelonin                                                 mAb (15A8)                                                          Breast cancer antigen                                                     Breast cancer, cervical cancer                                                                                                                                     Yes                                                  \[329\]

  Gelonin                                     HB5-gelonin                                                  mAb (HB5)                                                           Cd3 receptor                                                              EBV infection                                                                                                                                                      Yes                                                  \[330\]

  Gelonin                                     Anti-Lyt 2.2-gelonin                                         mAb (anti-Lyt 2.2) (19/178C1)                                       Lyt2.2                                                                    T-cell lymphoma                                                                                                                                                    Yes                                                  \[331\]

  Gelonin                                     Anti-Thy 1.2-gelonin                                         mAb (anti-Thy 1.2) (AT15E)                                          CD90.2 (Thy 1.2)                                                          T-cell lymphoma                                                                                                                                                    Yes                                                  \[331\]

  Gelonin                                     Anti-Thy 1-gelonin                                           mAb (anti-Thy 1) (M549)                                             CD90 (Thy 1.1 and 1.2)                                                    Leukemia                                                                                                                                                           Yes            Yes                                   \[332\]

  Gelonin                                     LG 2/72-gelonin                                              mAb (LG 2/72)                                                       HLA-DR                                                                    Lymphoma                                                                                                                                                           Yes                                                  \[331\]

  Gelonin                                     Anti-MCMV-gelonin                                            IgG (anti-MCMV)                                                     MCMV antigen (murine cytomegalovirus antigen)                             CMV infection                                                                                                                                                      Yes                                                  \[333\]

  Gelonin                                     Anti-HCMV-gelonin                                            IgG (anti-HCMV)                                                     HCMV antigen (human cytomegalovirus antigen)                              CMV infection                                                                                                                                                      Yes                                                  \[333\]

  Gelonin                                     Anti-JL1-gelonin                                             mAb (anti-JL1)                                                      JL1                                                                       Leukemia                                                                                                                                                           Yes                                                  \[334\]

  Gelonin                                     oLH-gelonin (lutropin-SS-gelonin)                            Ovine luteinizing hormone (oLH)                                     Ovine LH receptor                                                         Leydig cell tumor (testicular cancer)                                                                                                                              Yes                                                  \[335\]

  Gelonin                                     hCG-gelonin                                                  Human chorionic gonadotropin (hCG)                                  LH receptor                                                               Leydig cell tumor (testicular cancer)                                                                                                                              Yes                                                  \[335\]

  Gelonin                                     Gelonin-gp330                                                gp330 (renal brush border antigen)                                  Anti-gp330 Ig                                                             Heymann\'s nephritis                                                                                                                                               Yes            Yes                                   \[336\]

  Gelonin                                     Anti-PCV-gelonin                                             IgG (anti-PCV)                                                      Pichinde virus (PCV)                                                      Pichinde virus (PCV)                                                                                                                                               Yes                                                  \[337\]

  Gelonin                                     PC4.9A6-gelonin                                              mAb (PC4.9A6)                                                       Pichinde virus (PCV)                                                      Pichinde virus (PCV)                                                                                                                                               Yes                                                  \[337\]

  Gelonin                                     14G2a-gelonin                                                mAb (14G2a)                                                         Disialoganglioside GD2                                                    Neuroblastoma, melanoma                                                                                                                                            Yes                                                  \[338\]

  Gelonin                                     MSN-1-gelonin                                                mAb (MSN-1)                                                         Endometrial adenocarcinoma antigen                                        Endometrial adenocarcinoma                                                                                                                                         Yes            Yes                                   \[339\]

  Gelonin                                     F(ab\')2-gelonin/UCHT1                                       F(ab\')2 (anti-IgG) / mAb (UCHT1)                                   CD3                                                                       T-cell lymphoma                                                                                                                                                    Yes                                                  \[303\]

  Gelonin                                     H65-gelonin                                                  mAb (H65)                                                           CD5                                                                       T-cell ALL                                                                                                                                                         Yes            Yes                                   \[340\]

  Gelonin                                     BACH-250/rGel                                                mAb (BACH-250)                                                      HER2                                                                      Breast cancer                                                                                                                                                      Yes            Yes                                   \[341\]

  Gelonin                                     TAB-250/rGel                                                 mAb (TAB-250)                                                       HER2                                                                      Breast cancer                                                                                                                                                      Yes            Yes                                   \[341\]

  Gelonin                                     VEGF121/rGel                                                 VEGF121                                                             KDR Flk-1 receptor                                                        Tumor neovasculature, melanoma, prostate cancer                                                                                                                    Yes            Yes                                   \[342\]

  Gelonin                                     HuM195/rGel                                                  mAb (HuM-195)                                                       CD33                                                                      AML, CML, myelodysplastic syndrome                                                                                                                                 Yes            Yes           Phase I                 \[343-346\]

  Gelonin                                     MEL scFv-rGel                                                scFv (MEL)                                                          gp240                                                                     Melanoma, brain cancer, lobular breast cancer                                                                                                                      Yes            Yes                                   \[347\]

  Gelonin                                     BLyS-gelonin                                                 B lymphocyte stimulator (BLyS)                                      BR3/BAFF-R, TACI and BCMA                                                 B-NHL subtypes mantle cell lymphoma (MCL), diffuse large B-cell lymphoma (DLBCL), B-cell precursor-acute lymphocytic leukemia (BCP-ALL)                            Yes            Yes                                   \[348-350\]

  Gelonin                                     C6.5-rGel                                                    scFv (C6.5)                                                         HER2                                                                      Breast cancer, gastric cancer, lung cancer, ovarian cancer                                                                                                         Yes            Yes                                   \[351\]

  Gelonin                                     e23-L-rGel                                                   scFv (e23)                                                          HER2                                                                      Breast cancer, gastric cancer, lung cancer, ovarian cancer                                                                                                         Yes                                                  \[352\]

  Gelonin                                     ML3-9-rGel                                                   scFv (ML3-9)                                                        HER2                                                                      Breast cancer, gastric cancer, lung cancer                                                                                                                         Yes            Yes                                   \[351\]

  Gelonin                                     MH3-B1-rGel                                                  scFv (MH3-B1)                                                       HER2                                                                      Breast cancer, gastric cancer, lung cancer                                                                                                                         Yes            Yes                                   \[351\]

  Gelonin                                     B1D3-rGel                                                    scFv (B1D3)                                                         HER2                                                                      Breast cancer, gastric cancer, lung cancer                                                                                                                         Yes            Yes                                   \[351\]

  Gelonin                                     3ErGel                                                       scFv (sm3E)                                                         Carcinoembryonic antigen (CEA)                                            Colorectal cancer                                                                                                                                                  Yes                                                  \[353\]

  Gelonin                                     FErGel                                                       scFv (shMFE)                                                        Carcinoembryonic antigen (CEA)                                            Colorectal cancer                                                                                                                                                  Yes                                                  \[353\]

  Gelonin                                     C7rGel                                                       FN3 fragment (C743)                                                 Carcinoembryonic antigen (CEA)                                            Colorectal cancer                                                                                                                                                  Yes            Yes                                   \[353, 354\]

  Gelonin                                     E4rGel                                                       FN3 fragment (E246)                                                 EGFR                                                                      Colorectal cancer                                                                                                                                                  Yes            Yes                                   \[353, 354\]

  Gelonin                                     3C/rGel                                                      scFv (3C)                                                           FGFR3                                                                     Multiple myeloma, hepatocellular carcinoma, bladder cancer                                                                                                         Yes            Yes                                   \[355, 356\]

  Gelonin                                     7D/rGel                                                      scFv (7D)                                                           FGFR3                                                                     Multiple myeloma, hepatocellular carcinoma, bladder cancer                                                                                                         Yes            Yes                                   \[355\]

  Gelonin                                     H45-rGeloninD274C                                            mAb (H45)                                                           CD5                                                                       ALL                                                                                                                                                                Yes            Yes                                   \[357\]

  Gelonin                                     MOC31-gelonin                                                mAb (MOC31)                                                         Epithelial glycoprotein-2 (EGP-2)                                         SCLC, colon cancer, breast cancer                                                                                                                                  Yes                                                  \[358\]

  Luffa ribosomal inhibitory protein (LRIP)   HB21-LRIP                                                    mAb (HB21) (5E9)                                                    TfR                                                                       T lymphoblastic leukemia                                                                                                                                           Yes                                                  \[168\]

  Luffin-A                                    Luffin A-Ng76                                                mAb (Ng76)                                                          Melanoma antigen                                                          Melanoma                                                                                                                                                           Yes                                                  \[359\]

  Luffin-B                                    Luffin B-Ng76                                                mAb (Ng76)                                                          Melanoma antigen                                                          Melanoma                                                                                                                                                           Yes                                                  \[360\]

  Luffin-B                                    LKP (Luffin-β-KDEL-uPAcs)                                    uPAcs (urokinase-type plasminogen activator)                        Urokinase receptor                                                        Non-small cell lung cancer (NSCLC)                                                                                                                                 Yes                                                  \[361\]

  Luffin-P1                                   hIL-2-Luffin P1                                              IL-2                                                                CD25 (IL-2 receptor)                                                      Activated lymphocytes                                                                                                                                              Yes            Yes                                   \[362-364\]

  Luffin-P1                                   EBI3-Luffin P1                                               EBI3 (Epstein-Barr virus (EBV)-induced gene 3)                      CD25 (IL-2 receptor)                                                      Immunological diseases, erythroleukemia                                                                                                                            Yes                                                  \[365\]

  Mistletoe lectin I\                         Anti-CD5/MLIA                                                mAb (anti-CD5)                                                      CD5                                                                       T-lymphocytes                                                                                                                                                      Yes                                                  \[366\]
  A-chain                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Mistletoe lectin I\                         Anti-CD25/MLIA (Anti-CD25-MLA)                               mAb (anti-CD25)                                                     CD25 (IL-2 receptor)                                                      Activated lymphocytes                                                                                                                                              Yes                                                  \[367\]
  A-chain                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Mistletoe lectin I\                         MoAb-16-MLIA                                                 mAb (16)                                                            Oncofetal antigen                                                         Leukemia                                                                                                                                                           Yes                                                  \[368\]
  A-chain                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Mistletoe lectin I\                         BMAC1/MLA                                                    mAb (BMCA1)                                                         CD45                                                                      Allograft rejection                                                                                                                                                Yes                                                  \[369\]
  A-chain                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Mistletoe lectin I\                         OX1/MLA                                                      mAb (OX1)                                                           rat CD45                                                                  Allograft rejection                                                                                                                                                Yes                                                  \[369\]
  A-chain                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Momorcochin                                 Anti-epithelial antigen-momorcochin                          mAb (anti-epithelial antigen)                                       Epithelial antigen                                                        Colon cancer, epidermoid carcinoma                                                                                                                                 Yes                                                  \[302\]

  Momorcochin                                 F(ab\')2-momorcochin/UCHT1                                   F(ab\')2 (anti-IgG) / mAb (UCHT1)                                   CD3                                                                       T-cell lymphoma                                                                                                                                                    Yes                                                  \[303\]

  Momorcochin-S                               Momorcochin-S-A8                                             mAb (8A)                                                            8A myeloma antigen                                                        Burkitt lymphoma                                                                                                                                                   Yes            Yes                                   \[193\]

  Momordin                                    OX7-momordin                                                 mAb (anti-Thy 1.1) (OX7)                                            CD90.1 (Thy 1.1)                                                          AKR-A lymphoma                                                                                                                                                     Yes                                                  \[298\]

  Momordin                                    Fib 75-momordin                                              mAb (LICR-LOND Fib 75)                                              Bladder cancer antigen                                                    EJ bladder cancer                                                                                                                                                  Yes            Yes                                   \[284, 312\]

  Bryodin-1                                   F(ab\')2-bryodin/UCHT1                                       F(ab\')2 (anti-IgG) / mAb (UCHT1)                                   CD3                                                                       T-cell lymphoma                                                                                                                                                    Yes                                                  \[303\]

  Bryodin-2                                   chiBR96-BD-2                                                 scFv (BR96)                                                         Ley antigen                                                               Breast cancer                                                                                                                                                      Yes                                                  \[301\]

  Bryodin-2                                   HB21-bryodin-II                                              mAb (HB21) (5E9)                                                    TfR                                                                       Breast cancer                                                                                                                                                      Yes                                                  \[304\]

  Colocin 1                                   Anti-epithelial antigen-colocin 1                            mAb (anti-epithelial antigen)                                       Epithelial antigen                                                        Colon cancer, epidermoid carcinoma                                                                                                                                 Yes                                                  \[302\]

  Curcin                                      Curcin-TfRBP9                                                TfRBP9 \[transferrin receptor (TfR) binding peptide\]               TfR                                                                       Hepatocellular carcinoma                                                                                                                                           Yes                                                  \[305\]

  Dianthin 30                                 BerH2-dianthin                                               mAb (Ber-H2)                                                        CD30                                                                      Lymphoblastoid, Hodgkin\'s lymphoma                                                                                                                                Yes                                                  \[306, 307\]

  Dianthin 30                                 Dianthin-EGF                                                 EGF                                                                 EGFR                                                                      EGFR overexpressing cells                                                                                                                                          Yes                                                  \[84, 308\]

  Dianthin 30                                 Tfn-dianthin                                                 Transferrin                                                         TfR                                                                       T-cell leukemia                                                                                                                                                    Yes                                                  \[309\]

  Dianthin 32                                 F(ab\')2-dianthin 32/UCHT1                                   F(ab\')2 (anti-IgG) / mAb (UCHT1)                                   CD3                                                                       T-cell lymphoma                                                                                                                                                    Yes                                                  \[303\]

  Ebulin l                                    Ebulin l-transferrin                                         Transferrin                                                         TfR                                                                       TfR-over-expressing cancer cells                                                                                                                                   Yes                                                  \[310\]

  Ebulin l                                    44G4-ebulin                                                  mAb (44G4)                                                          CD105 (endoglin)                                                          Tumor neovasculature                                                                                                                                               Yes                                                  \[311\]

  Gelonin                                     Fib 75-gelonin                                               mAb (LICR-LOND Fib 75)                                              Bladder cancer antigen                                                    EJ bladder cancer                                                                                                                                                  Yes            Yes                                   \[284, 312\]

  Gelonin                                     Anti-CD86/gelonin (αCD86-gelonin)                            mAb (anti-CD86) (1G10)                                              CD86                                                                      Hodgkin\'s lymphoma, Burkitt\'s lymphoma                                                                                                                           Yes            Yes                                   \[295, 313\]

  Gelonin                                     Anti-CD80/gelonin (M24-gelonin)                              mAb (M24)                                                           CD80                                                                      Hodgkin\'s lymphoma, Burkitt\'s lymphoma                                                                                                                           Yes                                                  \[295\]

  Gelonin                                     αCD80-gelonin                                                mAb (B5B)                                                           CD80                                                                      Hodgkin\'s lymphoma, Burkitt\'s lymphoma                                                                                                                           Yes                                                  \[313\]

  Gelonin                                     J5/gelonin                                                   mAb (J5)                                                            CD10 (CALLA)                                                              Lymphoma                                                                                                                                                           Yes                                                  \[314\]

  Gelonin                                     I-2/gelonin                                                  mAb (I-2)                                                           Ia antigen                                                                Lymphoma                                                                                                                                                           Yes                                                  \[314\]

  Gelonin                                     J30/gelonin                                                  mAb (J30)                                                           gp26 cell surface glycoprotein                                            Lymphoma                                                                                                                                                           Yes                                                  \[314\]

  Gelonin                                     BerH2-gelonin                                                mAb (Ber-H2)                                                        CD30                                                                      Hodgkin\'s lymphoma                                                                                                                                                Yes                                                  \[307\]

  Gelonin                                     NDA4-gelonin                                                 mAb (NDA4)                                                          NDA4 antigen                                                              EBV-transformed lymphoblastoid, gibbon MLA leukemia                                                                                                                Yes                                                  \[315\]

  Gelonin                                     HB21-gelonin (5E9-gelonin)                                   mAb (HB21) (5E9)                                                    TfR                                                                       Colon cancer, Burkitt\'s lymphoma                                                                                                                                  Yes            Yes                                   \[157, 316\]

  Gelonin                                     OKT9-gelonin                                                 mAb (OKT9)                                                          TfR                                                                       Cervical cancer                                                                                                                                                    Yes                                                  \[317\]

  Momordin                                    OM124-momordin                                               mAb (anti-CD22) (OM124)                                             CD22                                                                      Burkitt\'s B-cell lymphoma, Epstein-Barr virus-infected B lymphoblastoid cells                                                                                     Yes            Yes                                   \[370\]

  Momordin                                    8A-Momordin                                                  mAb (8A)                                                            8A myeloma antigen                                                        Multiple myeloma                                                                                                                                                   Yes                                                  \[371\]

  Momordin                                    Anti-CD5-Momordin                                            mAb (anti-CD5)                                                      CD5                                                                       T-cell leukemia                                                                                                                                                    Yes            Yes                                   \[372\]

  Momordin                                    Anti-CD30-Momordin (Ber-H2-Momordin)                         mAb (Ber-H2)                                                        CD30                                                                      Hodgkin\'s lymphoma, anaplastic large-cell lymphoma(ALCL)                                                                                                          Yes            Yes                                   \[307, 373, 374\]

  Momordin                                    BDI-1-momordin                                               mAb (BDI-1)                                                         Bladder cancer antigen                                                    Bladder cancer                                                                                                                                                     Yes            Yes           Phase I                 \[375, 376\]

  Momordin                                    Folate-momordin                                              Folate                                                              Folate receptor                                                           Cervical cancer, ovarian cancer                                                                                                                                    Yes                                                  \[377, 378\]

  Momordin                                    Anti-epithelial antigen-momordin                             mAb (anti-epithelial antigen)                                       Epithelial antigen                                                        Colon cancer, epidermoid carcinoma                                                                                                                                 Yes                                                  \[302\]

  Momordin                                    F(ab\')2-momordin/UCHT1                                      F(ab\')2 (anti-IgG) / mAb (UCHT1)                                   CD3                                                                       T-cell lymphoma                                                                                                                                                    Yes                                                  \[303\]

  Momordin I                                  48-127/momordin I                                            mAb (48-127)                                                        gp54                                                                      Bladder cancer                                                                                                                                                     Yes                                                  \[379\]

  Moschatin                                   Moschatin-Ng76                                               mAb (Ng76)                                                          Melanoma antigen                                                          Melanoma                                                                                                                                                           Yes                                                  \[380\]

  Nigrin b                                    44G4-nigrin b                                                mAb (44G4)                                                          CD105 (endoglin)                                                          Tumor neovasculature                                                                                                                                               Yes                                                  \[381\]

  Nigrin b                                    MJ7-Ngb                                                      mAb (MJ7/18)                                                        CD105 (endoglin)                                                          Tumor neovasculature, melanoma                                                                                                                                     Yes            Yes                                   \[382, 383\]

  Nigrin b                                    Nigrin b-transferrin                                         Transferrin                                                         TfR                                                                       TfR-over-expressing cancer cells                                                                                                                                   Yes                                                  \[310\]

  Ocymoidine                                  Mint-Ocy                                                     mAb (Mint5)                                                         EGFR                                                                      Breast cancer                                                                                                                                                      Yes            Yes                                   \[384\]

  PAP                                         B43-PAP                                                      mAb (B43)                                                           CD19                                                                      Leukemia, B-cell ALL                                                                                                                                               Yes            Yes           Phase I                 \[385-388\]

  PAP                                         TXU-PAP                                                      mAb (TXU)                                                           CD7                                                                       T-NHL, HIV type I                                                                                                                                                  Yes            Yes           Phase I                 \[389-391\]

  PAP                                         Anti-Thy 1.1 (mAb)-PAP                                       mAb (anti-Thy 1.1) (OX7)                                            CD90.1 (Thy 1.1)                                                          Leukemia                                                                                                                                                           Yes                                                  \[392\]

  PAP                                         Anti-Thy 1.1 (F(ab\')2)-PAP                                  F(ab\')2 (anti-Thy 1.1) (OX7)                                       CD90.1 (Thy 1.1)                                                          Leukemia                                                                                                                                                           Yes                                                  \[392\]

  PAP                                         GnRH-PAP                                                     Gonadotropinreleasing hormone (GnRH)                                GnRH receptor                                                             Breast cancer                                                                                                                                                      Yes                                                  \[393, 394\]

  PAP                                         TP3-PAP                                                      mAb (TP3)                                                           p80                                                                       Osteosarcoma                                                                                                                                                       Yes            Yes                                   \[395\]

  PAP                                         J3-109-PAP                                                   mAb (J3-109)                                                        CD72                                                                      B-cell ALL                                                                                                                                                         Yes                                                  \[396\]

  PAP                                         74-12-4-PAP                                                  mAb (74-12-4)                                                       porcine CD4                                                               Transplants                                                                                                                                                                       Yes                                   \[397\]

  PAP                                         Anti-CD4-PAP                                                 mAb (MT151)                                                         CD4                                                                       HIV                                                                                                                                                                Yes                                                  \[398\]

  PAP                                         PAP-9.2.27                                                   mAb (9.2.27)                                                        Melanoma-associated antigen (p250)                                        Melanoma                                                                                                                                                           Yes            Yes                                   \[280, 399\]

  PAP                                         J5/PAP                                                       mAb (J5)                                                            CD10 (CALLA)                                                              Lymphoma                                                                                                                                                           Yes                                                  \[314\]

  PAP9 (High expressed mutated PAP)           PAP9-IL-2                                                    IL-2                                                                CD25 (IL-2 receptor)                                                      T-cell lymphoma                                                                                                                                                    Yes                                                  \[400\]

  PAP II                                      J5/PAP II                                                    mAb (J5)                                                            CD10 (CALLA)                                                              Lymphoma                                                                                                                                                           Yes                                                  \[314\]

  PAP-S                                       OM124-PAP-S                                                  mAb (anti-CD22) (OM124)                                             CD22                                                                      Burkitt\'s B-cell lymphoma, Epstein-Barr virus-infected B lymphoblastoid cells, Hodgkin\'s lymphoma                                                                Yes            Yes                                   \[307, 370\]

  PAP-S                                       Anti-CD30-PAP-S (Ber-H2-PAP-S)                               mAb (Ber-H2)                                                        CD30                                                                      Hodgkin\'s lymphoma, anaplastic large-cell lymphoma(ALCL)                                                                                                          Yes            Yes                                   \[373, 401\]

  PAP-S                                       48-127/PAP-S                                                 mAb (48-127)                                                        gp54                                                                      Bladder cancer                                                                                                                                                     Yes                                                  \[379\]

  PAP-S                                       Anti-epithelial antigen-PAP-S                                mAb (anti-epithelial antigen)                                       Epithelial antigen                                                        Colon cancer, epidermoid carcinoma                                                                                                                                 Yes                                                  \[302\]

  PAP-S                                       F(ab\')2-PAP-S/UCHT1                                         F(ab\')2 (anti-IgG) / mAb (UCHT1)                                   CD3                                                                       T-cell lymphoma                                                                                                                                                    Yes                                                  \[303\]

  PAP-S                                       J5/PAP-S                                                     mAb (J5)                                                            CD10 (CALLA)                                                              Lymphoma                                                                                                                                                           Yes                                                  \[314\]

  PD-S2                                       Ber-H2-PD-S2                                                 mAb (Ber-H2)                                                        CD30                                                                      Hodgkin\'s lymphoma                                                                                                                                                Yes                                                  \[307\]

  Pyramidatine                                Mint-Pyra                                                    mAb (Mint5)                                                         EGFR                                                                      Breast cancer                                                                                                                                                      Yes            Yes                                   \[384\]

  Ricin                                       Anti-Ly2.1-ricin                                             mAb (anti-Ly2.1)                                                    Murine T-cell antigen                                                     T-cell ALL                                                                                                                                                         Yes            Yes                                   \[402\]

  Ricin                                       Anti-CD8-ricin                                               mAb (B9.4.2)                                                        CD8                                                                       PBMCs                                                                                                                                                              Yes                                                  \[403\]

  Ricin                                       Anti-CD4-ricin                                               mAb (HP2/6)                                                         CD4                                                                       PBMCs                                                                                                                                                              Yes                                                  \[403\]

  Ricin                                       Anti-CD3-ricin                                               mAb (SPV-T3b)                                                       CD3                                                                       PBMCs                                                                                                                                                              Yes                                                  \[403\]

  Ricin                                       Anti-CD3-ricin                                               mAb (11D8)                                                          CD3                                                                       PBMCs                                                                                                                                                              Yes                                                  \[403\]

  Ricin                                       UCHT1-ricin                                                  mAb (UCHT1)                                                         CD3ε                                                                      GVHD                                                                                                                                                               Yes                                                  \[404\]

  Ricin                                       35.1-ricin                                                   mAb (35.1)                                                          CD2                                                                       GVHD                                                                                                                                                               Yes                                                  \[404\]

  Ricin                                       T101-ricin                                                   mAb (T101)                                                          CD5                                                                       GVHD                                                                                                                                                               Yes            Yes                                   \[404, 405\]

  Ricin                                       Ricin-HB55                                                   mAb (BH55)                                                          HLA-DR                                                                    B-cell leukemia, lymphoma                                                                                                                                          Yes                                                  \[406\]

  Ricin                                       IL2-lectin-deficient RTB-RTA                                 IL-2                                                                CD25 (IL-2 receptor)                                                      Leukemia                                                                                                                                                           Yes                                                  \[407\]

  Ricin                                       GMCSF-ricin                                                  GMCSF                                                               GMCSF receptor                                                            AML                                                                                                                                                                Yes                                                  \[408\]

  Ricin                                       M6-ricin                                                     mAb (M6)                                                            L2C IgM idiotype                                                          B-cell leukemia                                                                                                                                                    Yes            Yes                                   \[409\]

  Ricin                                       Anti-GE2-ricin                                               mAb (anti-GE2)                                                      GE2                                                                       Glioma                                                                                                                                                             Yes                                                  \[410\]

  Ricin                                       AR3-ricin                                                    mAb (AR3)                                                           CAR-3                                                                     Gastric cancer, colorectal cancer                                                                                                                                  Yes                                                  \[411\]

  Ricin                                       BDI-1-ricin                                                  mAb (BDI-1)                                                         Bladder cancer antigen                                                    Bladder cancer                                                                                                                                                     Yes                                                  \[412\]

  Ricin                                       Ricin-mAb 35                                                 mAb (35)                                                            AChR (nicotinic acetylcholine receptor)                                   Strabismus                                                                                                                                                         Yes            Yes                                   \[413, 414\]

  Ricin                                       Anti-Lyt 2.2-ricin                                           mAb (anti-Lyt 2.2) (19/178C1)                                       Lyt2.2                                                                    T-cell lymphoma                                                                                                                                                    Yes                                                  \[331\]

  Ricin                                       IgE-intact ricin                                             mAb (IR162)                                                         IgE Fc receptor                                                           Allergies, basophil leukemia                                                                                                                                       Yes                                                  \[415\]

  Ricin                                       L6-ricin                                                     mAb (L6)                                                            Lung canger antigen                                                       Lung cancer                                                                                                                                                        Yes            Yes                                   \[416\]

  Ricin                                       Ricin-EGF                                                    EGF                                                                 EGFR                                                                      Epidermoid carcinoma                                                                                                                                               Yes                                                  \[417\]

  Ricin                                       Anti-CD6-bR                                                  mAb (anti-CD6)                                                      CD6                                                                       CTCL, ALL                                                                                                                                                          Yes            Yes           Phase I                 \[418, 419\]

  Ricin                                       Anti-B4-bR                                                   mAb (anti-B4)                                                       CD19                                                                      B-NHL                                                                                                                                                              Yes            Yes           Phase III               \[420-425\]

  Ricin                                       Anti-My9-bR                                                  mAb (anti-My9)                                                      CD33                                                                      AML                                                                                                                                                                Yes            Yes           Phase I                 \[418, 426, 427\]

  Ricin                                       N901-bR                                                      mAb (N901)                                                          CD56 (N-CAM)                                                              SCLC                                                                                                                                                               Yes            Yes           Phase II                \[418, 428-431\]

  Ricin                                       Anti-CEA-bR                                                  mAb (I-1)                                                           Carcinoembryonic antigen (CEA)                                            Colorectal cancer                                                                                                                                                  Yes            Yes           Phase I/II              \[432\]

  Ricin                                       IF7-bR                                                       mAb (IF7)                                                           CD26                                                                      T cells                                                                                                                                                            Yes                                                  \[433\]

  Ricin                                       4B4-bR                                                       mAb (4B4)                                                           CD29                                                                      Lymphocytes, endothelium                                                                                                                                           Yes                                                  \[304\]

  Ricin                                       MT151-blocked ricin                                          mAb (MT151)                                                         CD4                                                                       ALL                                                                                                                                                                Yes                                                  \[434\]

  Ricin                                       Anti-CD4.CD26-bRicin                                         Bispecific mAb (anti-CD4 x CD26)                                    CD4 + CD26                                                                GVHD                                                                                                                                                               Yes                                                  \[433\]

  Ricin                                       Anti-CD4-bRicin                                              Fab\' (19thy5D7)                                                    CD4                                                                       GVHD                                                                                                                                                               Yes                                                  \[433\]

  Ricin                                       Anti-CD26-bRicin                                             Fab\' (1F7)                                                         CD26                                                                      GVHD                                                                                                                                                               Yes                                                  \[433\]

  Ricin                                       Anti-CD4.CD29-bRicin                                         Bispecific mAb (anti-CD4 x CD29)                                    CD4 + CD29                                                                Tissue allografts                                                                                                                                                  Yes                                                  \[435\]

  Ricin                                       SEN31-bR                                                     mAb (SEN31)                                                         Cluster-5a antigen                                                        SCLC                                                                                                                                                               Yes            Yes                                   \[436\]

  Ricin                                       HB7-blocked ricin                                            mAb (HB7)                                                           CD38                                                                      Multiple myeloma, lymphoma                                                                                                                                         Yes                                                  \[437\]

  RTA                                         Anti-Thy 1.1-dgRTA                                           mAb (anti-Thy 1.1) (OX7)                                            CD90.1 (Thy 1.1)                                                          AKR-A lymphoma                                                                                                                                                     Yes            Yes                                   \[438\]

  RTA                                         Anti-CD7-dgA (DA7)                                           mAb (3A1e)                                                          CD7                                                                       T-NHL, leukemia, GVHD                                                                                                                                              Yes            Yes           Phase I                 \[439\]

  RTA                                         HD37-dgA (IMTOX-19)                                          mAb (HD37)                                                          CD19                                                                      B-NHL, ALL                                                                                                                                                         Yes            Yes           Phase I                 \[440, 441\]

  RTA                                         RFB4-Fab\'-dgA                                               Fab' (RFB4)                                                         CD22                                                                      B-NHL, leukemia, lymphoma                                                                                                                                          Yes            Yes           Phase I                 \[442, 443\]

  RTA                                         RFT5-dgA (IMTOX-25)                                          mAb (RFT5)                                                          CD25                                                                      Hodgkin\'s lymphoma, CTCL, melanoma, GVHD                                                                                                                          Yes            Yes           Phase II                \[444-448\]

  RTA                                         Ki-4.dgA                                                     mAb (Ki-4)                                                          CD30                                                                      Hodgkin\'s lymphoma, NHL                                                                                                                                           Yes            Yes           Phase I                 \[447, 449, 450\]

  RTA                                         RFB4-dgA (IMTOX-22)                                          mAb (RFB4)                                                          CD22                                                                      B-NHL, CLL, ALL, leukemia, lymphoma, myeloma                                                                                                                       Yes            Yes           Phase I                 \[443, 451, 452\]

  RTA                                         Combotox (RFB4-dgA / HD37-dgA)                               mAb (RFB4) + mAb (HD37)                                             CD22, CD19                                                                NHL, ALL                                                                                                                                                           Yes            Yes           Phase I                 \[453, 454\]

  RTA                                         SPV-T3a-dgA + WT1-dgA                                        mAb (SPV-T3a) + mAb (WT1)                                           CD3, CD7                                                                  GVHD                                                                                                                                                               Yes            Yes           Phase I/II              \[455, 456\]

  RTA                                         3A1e-dgRTA                                                   scFv (3A1e)                                                         CD7                                                                       T-cell leukemia                                                                                                                                                    Yes                                                  \[457\]

  RTA                                         3AIf-dgRTA                                                   scFv (3A1f)                                                         CD7                                                                       T-cell leukemia                                                                                                                                                    Yes                                                  \[457\]

  RTA                                         UV3-dgRTA                                                    mAb (UV3)                                                           CD54 (ICAM-1)                                                             Myeloma, grnulocytes, monocytes                                                                                                                                    Yes                                                  \[458\]

  RTA                                         H22-dgRTA (CD64-RiA)                                         mAb (H22)                                                           CD64                                                                      AML, rheumatoid arthritis, monocytes, macrophages                                                                                                                  Yes            Yes                                   \[459-461\]

  RTA                                         D5-dgA                                                       mAb (D5)                                                            Cytomegalovirus                                                           Cytomegalovirus (MCMV)                                                                                                                                             Yes                                                  \[462\]

  RTA                                         C34-dgA                                                      mAb (C34)                                                           Cytomegalovirus                                                           Cytomegalovirus (MCMV)                                                                                                                                             Yes                                                  \[462\]

  RTA                                         HMS-dgA                                                      IgG (HMS)                                                           Cytomegalovirus                                                           Cytomegalovirus (MCMV)                                                                                                                                             Yes                                                  \[462\]

  RTA                                         64.1-dgRTA                                                   mAb (64.1)                                                          CD3                                                                       Lymphoproliferative disease (LPD)                                                                                                                                  Yes            Yes                                   \[463, 464\]

  RTA                                         HD6-dgA                                                      mAb (HD6)                                                           CD22                                                                      Leukemia, lymphoma                                                                                                                                                 Yes                                                  \[443\]

  RTA                                         HD6-Fab\'-dgA                                                Fab' (HD6)                                                          CD22                                                                      Leukemia, lymphoma                                                                                                                                                 Yes                                                  \[443\]

  RTA                                         UV22-1-dgA                                                   mAb (UV22-1)                                                        CD22                                                                      Leukemia, lymphoma                                                                                                                                                 Yes                                                  \[443\]

  RTA                                         UV22-1-Fab\'-dgA                                             Fab' (UV22-1)                                                       CD22                                                                      Leukemia, lymphoma                                                                                                                                                 Yes                                                  \[443\]

  RTA                                         UV22-2-dgA                                                   mAb (UV22-2)                                                        CD22                                                                      Leukemia, lymphoma                                                                                                                                                 Yes                                                  \[443\]

  RTA                                         UV22-2-Fab\'-dgA                                             Fab' (UV22-2)                                                       CD22                                                                      Leukemia, lymphoma                                                                                                                                                 Yes                                                  \[443\]

  RTA                                         p67.7-dgA                                                    mAb (p67.7)                                                         CD33                                                                      AML                                                                                                                                                                Yes                                                  \[465\]

  RTA                                         120-2A3-dgA                                                  mAb (120-2A3)                                                       TfR                                                                       Myeloma, Hodgkin\'s lymphoma                                                                                                                                       Yes                                                  \[465\]

  RTA                                         B-B10-dgA                                                    mAb (B-B10)                                                         CD25 (IL-2 receptor)                                                      Myeloma, Hodgkin\'s lymphoma                                                                                                                                       Yes                                                  \[465\]

  RTA                                         TDR31-1-dgA                                                  mAb (TDR31-1)                                                       MHC class II                                                              Myeloma, Hodgkin\'s lymphoma                                                                                                                                       Yes                                                  \[465\]

  RTA                                         SWA11-dg.RTA                                                 mAb (SWA11)                                                         CD24                                                                      SCLC                                                                                                                                                               Yes            Yes                                   \[466, 467\]

  RTA                                         M5/114-dgA                                                   mAb (M5/114)                                                        MCH Class II antigens (I-Ad, I-Ed)                                        Endothelial cells                                                                                                                                                  Yes            Yes                                   \[468\]

  RTA                                         11-4.1-dgA                                                   mAb (11-4.1)                                                        MCH Class I antigen (H-2Kk)                                               Neuroblastoma                                                                                                                                                      Yes            Yes                                   \[468, 469\]

  RTA                                         E6-dgA                                                       mAb (E6)                                                            Prostate-specific membrane antigen (PSMA)                                 Prostate cancer                                                                                                                                                    Yes            Yes                                   \[470\]

  RTA                                         14G2a.dgA                                                    mAb (14G2a)                                                         Disialoganglioside GD2                                                    Neuroblastoma                                                                                                                                                      Yes            Yes                                   \[471\]

  RTA                                         ch14.18.dgA                                                  mAb (ch14.18)                                                       Disialoganglioside                                                        Neuroblastoma                                                                                                                                                      Yes                                                  \[471\]

  RTA                                         BW704.dgA                                                    mAb (BW704)                                                         Disialoganglioside                                                        Neuroblastoma                                                                                                                                                      Yes                                                  \[471\]

  RTA                                         chCE7.dgA                                                    mAb (chCE7)                                                         190 kDa Glycoprotein (gp190)                                              Neuroblastoma                                                                                                                                                      Yes                                                  \[471\]

  RTA                                         FVS191cys-dgRTA                                              scFv (FVS191)                                                       CD19                                                                      Leukemia                                                                                                                                                           Yes                                                  \[472\]

  RTA                                         K4-2C10-dgRA                                                 mAb (K4-2C10)                                                       CD105 (endoglin)                                                          Tumor neovasculature, breast cancer                                                                                                                                Yes            Yes                                   \[473\]

  RTA                                         SN6j-dgRA                                                    mAb (SN6j)                                                          CD105 (endoglin)                                                          Tumor neovasculature, breast cancer                                                                                                                                Yes            Yes                                   \[474\]

  RTA                                         SN6k-dgRA                                                    mAb (SN6k)                                                          CD105 (endoglin)                                                          Tumor neovasculature, breast cancer                                                                                                                                Yes            Yes                                   \[474\]

  RTA                                         D5-dgA                                                       mAb (D5)                                                            MCMV antigen (murine cytomegalovirus antigen)                             CMV infection                                                                                                                                                      Yes            Yes                                   \[462, 475\]

  RTA                                         C34-dgA                                                      mAb (C34)                                                           MCMV antigen (murine cytomegalovirus antigen)                             CMV infection                                                                                                                                                      Yes            Yes                                   \[462, 475\]

  RTA                                         FF1-4D5-dgA                                                  mAb (FF1-4D5)                                                       mouse δ H chain of surface IgD (mδsIgD), domain Fd                        B-cells                                                                                                                                                            Yes                                                  \[476\]

  RTA                                         AMS-15.1-dgA                                                 mAb (AMS-15.1)                                                      mouse δ H chain of surface IgD (mδsIgD), domain Fd                        B-cells                                                                                                                                                            Yes                                                  \[476\]

  RTA                                         11-26-dgA                                                    mAb (11-26)                                                         mouse δ H chain of surface IgD (mδsIgD), domain Fd                        B-cells                                                                                                                                                            Yes                                                  \[476\]

  RTA                                         JA12.5-dgA                                                   mAb (JA12.5)                                                        mouse δ H chain of surface IgD (mδsIgD), domain Fd                        B-cells                                                                                                                                                            Yes                                                  \[476\]

  RTA                                         AMS-9.1-dgA                                                  mAb (AMS-9.1)                                                       mouse δ H chain of surface IgD (mδsIgD), domain Fc                        B-cells                                                                                                                                                            Yes                                                  \[476\]

  RTA                                         AMS-28.1-dgA                                                 mAb (AMS-28.1)                                                      mouse δ H chain of surface IgD (mδsIgD), domain Fc                        B-cells                                                                                                                                                            Yes                                                  \[476\]

  RTA                                         Hδa/1-dgA                                                    mAb (Hδa/1)                                                         mouse δ H chain of surface IgD (mδsIgD), domain Fc                        B-cells                                                                                                                                                            Yes                                                  \[476\]

  RTA                                         UCHL1-dgA                                                    mAb (UCHL1)                                                         CD45RO                                                                    HIV                                                                                                                                                                Yes                                                  \[477-479\]

  RTA                                         My7/Fab\' GAMIg.dgA                                          mAb (My7) / Fab\' (GAM Ig)                                          CD13                                                                      Myeloid leukemia                                                                                                                                                   Yes                                                  \[465\]

  RTA                                         1G10/Fab\' GAMIg.dgA                                         mAb (My7) / Fab\' (GAM Ig)                                          CD15                                                                      Myeloid leukemia                                                                                                                                                   Yes                                                  \[465\]

  RTA                                         rCD4-dgA                                                     rCD4 (recombinant CD4)                                              HIVgp120                                                                  HIV                                                                                                                                                                Yes                                                  \[480\]

  RTA                                         Fib 75-ricin A chain                                         mAb (LICR-LOND Fib 75)                                              Bladder cancer antigen                                                    Bladder cancer                                                                                                                                                     Yes            Yes                                   \[282-284\]

  RTA                                         ITR                                                          IgG (anti-Trypanosoma cruzi surface antigens)                       Trypanosoma cruzi surface antigens                                        *Trypanosoma cruz*i                                                                                                                                                Yes                                                  \[288\]

  RTA                                         Anti-CD25/RTA                                                mAb (anti-CD25)                                                     CD25 (IL-2 receptor)                                                      Activated lymphocytes                                                                                                                                              Yes                                                  \[367, 407\]

  RTA                                         Anti-CD5/RTA                                                 mAb (anti-CD5)                                                      CD5                                                                       T-lymphocytes                                                                                                                                                      Yes                                                  \[366\]

  RTA                                         BerH2-RTA                                                    mAb (Ber-H2)                                                        CD30                                                                      Lymphoblastoid, Hodgkin\'s lymphoma                                                                                                                                Yes                                                  \[374, 481\]

  RTA                                         H65-RTA (CD5 Plus) (XomaZyme-CD5 Plus)                       mAb (H65)                                                           CD5                                                                       GVHD, CTCL, CLL, rheumatoid arthritis, systemic lupus erythematosus (SLE), diabetes mellitus                                                                       Yes            Yes           Phase II                \[482-487\]

  RTA                                         454A12-rRA                                                   mAb (454A12)                                                        TfR                                                                       Breast cancer, leptomeningeal neoplasia                                                                                                                            Yes            Yes           Phase I                 \[488, 489\]

  RTA                                         260F9-rRTA                                                   mAb (260F9)                                                         55 kDa breast cancer antigen (p55)                                        Breast cancer, ovarian cancer                                                                                                                                      Yes            Yes           Phase I                 \[490-492\]

  RTA                                         XMMME-001-RTA (XomaZyme-Mel)                                 mAb (XMMME-001)                                                     Melanoma antigen (Proteoglycan)                                           Melanoma                                                                                                                                                           Yes            Yes           Phase I/II              \[493-498\]

  RTA                                         791T/36-RTA (XomaZyme-791)                                   mAb (791T/36)                                                       72 kDa cancer antigen (72 kDa TAA) (p72)                                  Colorectal cancer                                                                                                                                                  Yes            Yes           Phase I                 \[499, 500\]

  RTA                                         T101-RTA                                                     mAb (T101)                                                          CD5                                                                       CLL                                                                                                                                                                Yes            Yes           Phase I                 \[501-503\]

  RTA                                         T101-RTA                                                     Fab (T101)                                                          CD5                                                                       T-cell leukemia                                                                                                                                                    Yes                                                  \[504\]

  RTA                                         T101-RTA                                                     F(ab\')2 (T101)                                                     CD5                                                                       T-cell leukemia                                                                                                                                                    Yes                                                  \[504\]

  RTA                                         MDX-RA (4197X-RA)                                            mAb (4197X)                                                         Human lens epithelial antigen                                             Posterior capsule opacification (secondary cataract)                                                                                                                              Yes           Phase III               \[505-507\]

  RTA                                         RTA-EGF                                                      EGF                                                                 EGFR                                                                      Epidermoid carcinoma, EGFR+ cells                                                                                                                                  Yes                                                  \[84, 417, 508\]

  RTA                                         WT82-RTA                                                     mAb (WT82)                                                          CD8                                                                       T-cell ALL                                                                                                                                                         Yes                                                  \[509\]

  RTA                                         2G5-RTA                                                      mAb (2G5)                                                           HLA-DR                                                                    Lymphoma, B cells, T cells, dendritic cells                                                                                                                        Yes                                                  \[510\]

  RTA                                         CLL2m-RTA                                                    mAb (CLL2m)                                                         CLL2m antigen                                                             ND, CLL                                                                                                                                                            Yes                                                  \[511\]

  RTA                                         HAE3-RTA                                                     mAb (HAE3)                                                          Glycophorin-A                                                             Erythromyeloblastoid leukemia                                                                                                                                      Yes                                                  \[512\]

  RTA                                         HAE9-RTA                                                     mAb (HAE9)                                                          Erythroid antigen                                                         Erythromyeloblastoid leukemia                                                                                                                                      Yes                                                  \[512\]

  RTA                                         BMAC1/RTA                                                    mAb (BMCA1)                                                         CD45                                                                      Allograft rejection                                                                                                                                                Yes                                                  \[369\]

  RTA                                         OX1/RTA                                                      mAb (OX1)                                                           rat CD45                                                                  Allograft rejection                                                                                                                                                Yes                                                  \[369\]

  RTA                                         SN7-RTA                                                      mAb (SN7)                                                           SN7 B-cell antigen                                                        B-cell leukemia, B-cell lymphoma                                                                                                                                   Yes            Yes                                   \[513\]

  RTA                                         HB21-RTA                                                     mAb (HB21) (5E9)                                                    TfR                                                                       Ovarian cancer, epidermoid carcinoma                                                                                                                               Yes                                                  \[492\]

  RTA                                         R17217-rRTA                                                  mAb (R17217)                                                        Murine TfR                                                                Lymphoma                                                                                                                                                           Yes            Yes                                   \[514\]

  RTA                                         YE1/9.9-rRTA                                                 mAb (YE1/9.9)                                                       Murine TfR                                                                Lymphoma                                                                                                                                                           Yes                                                  \[514\]

  RTA                                         0.5beta-RTA                                                  mAb (0.5beta)                                                       HIV gp120                                                                 HIV                                                                                                                                                                Yes                                                  \[515\]

  RTA                                         Anti-gp120-RTA                                               mAb (anti-gp120)                                                    HIV gp120                                                                 HIV                                                                                                                                                                Yes                                                  \[516\]

  RTA                                         Anti-gp120-RTA                                               IgG (anti-gp120)                                                    HIV gp120                                                                 HIV                                                                                                                                                                Yes                                                  \[517\]

  RTA                                         Anti-gp41-RTA                                                mAb (7B2)                                                           HIV gp120                                                                 HIV                                                                                                                                                                Yes            Yes                                   \[516, 518, 519\]

  RTA                                         171A-RTA                                                     mAb (171A)                                                          EpCAM                                                                     Colorectal cancer                                                                                                                                                  Yes                                                  \[520\]

  RTA                                         MT151-RTA                                                    mAb (MT151)                                                         CD4                                                                       ALL                                                                                                                                                                Yes                                                  \[434\]

  RTA                                         MRK-RTA                                                      mAb (MRK16)                                                         P-glycoprotein                                                            Kidney cancer                                                                                                                                                      Yes                                                  \[521\]

  RTA                                         KM231-RTA                                                    mAb (KM231)                                                         Sialyl-Lea-antigen                                                        Gastric cancer, colorectal cancer                                                                                                                                  Yes            Yes                                   \[522\]

  RTA                                         UCHT1 F(ab\')2-RTA                                           F(ab\')2 (UCHT1)                                                    CD3ε                                                                      GVHD                                                                                                                                                               Yes            Yes                                   \[523\]

  RTA                                         WT32-RTA                                                     mAb (WT32)                                                          CD3                                                                       T-cell ALL                                                                                                                                                         Yes                                                  \[524\]

  RTA                                         WT1-RTA                                                      mAb (WT1)                                                           CD7                                                                       T-cell ALL, lymphoma                                                                                                                                               Yes                                                  \[524, 525\]

  RTA                                         528-rRA                                                      mAb (528)                                                           EGFR                                                                      Lung cancer                                                                                                                                                        Yes            Yes                                   \[526\]

  RTA                                         Anti-Tac-RTA                                                 mAb (anti-CD25)                                                     CD25 (IL-2 receptor)                                                      T-cell leukemia, activated lymphocytes                                                                                                                             Yes                                                  \[367, 527\]

  RTA                                         Tf-RTA                                                       Transferrin                                                         TfR                                                                       T-cell ALL, prostate cancer, malaria (*Plasmodium falciparum*)                                                                                                     Yes                                                  \[327, 528, 529\]

  RTA                                         Tf-KFT25-RTA                                                 Transferrin                                                         TfR                                                                       T-cell ALL                                                                                                                                                         Yes                                                  \[528\]

  RTA                                         520C9-RTA                                                    mAb (520C9)                                                         HER2                                                                      Breast cancer                                                                                                                                                      Yes                                                  \[530\]

  RTA                                         741 F8-RTA                                                   mAb (741 F8)                                                        HER2                                                                      Breast cancer                                                                                                                                                      Yes                                                  \[530\]

  RTA                                         454C11-RTA                                                   mAb (454C11)                                                        HER2                                                                      Breast cancer                                                                                                                                                      Yes                                                  \[530\]

  RTA                                         STI-RTA                                                      mAb (STI)                                                           CD5                                                                       T-cell ALL                                                                                                                                                         Yes                                                  \[531\]

  RTA                                         RTA-9.2.27                                                   mAb (9.2.27)                                                        Melanoma-associated antigen (p250)                                        Melanoma                                                                                                                                                           Yes            Yes                                   \[280\]

  RTA                                         BrE-3-RTA                                                    mAb (BrE-3)                                                         Mucin, MUC1                                                               SCLC                                                                                                                                                               Yes                                                  \[532\]

  RTA                                         C242-RTA (ICI D0490)                                         mAb (C242)                                                          Mucin                                                                     Colorectal cancer                                                                                                                                                  Yes            Yes                                   \[533\]

  RTA                                         84.1c-RTA                                                    mAb (84.1c)                                                         mIgE                                                                      Allergies                                                                                                                                                          Yes            Yes                                   \[534\]

  RTA                                         HRS-3.dgA                                                    mAb (HRS-3)                                                         CD30                                                                      Hodgkin\'s lymphoma, myeloma                                                                                                                                       Yes                                                  \[465, 535\]

  RTA                                         HRS-3Fab\'.dgA                                               Fab\' (HRS-3)                                                       CD30                                                                      Hodgkin\'s lymphoma                                                                                                                                                Yes                                                  \[535\]

  RTA                                         HRS-4.dgA                                                    mAb (HRS-4)                                                         CD30                                                                      Hodgkin\'s lymphoma                                                                                                                                                Yes                                                  \[535\]

  RTA                                         HRS-4Fab\'.dgA                                               Fab\' (HRS-4)                                                       CD30                                                                      Hodgkin\'s lymphoma                                                                                                                                                Yes                                                  \[535\]

  RTA                                         HRS-1.dgA                                                    mAb (HRS-1)                                                         CD30                                                                      Hodgkin\'s lymphoma                                                                                                                                                Yes                                                  \[535\]

  RTA                                         90Y-C110-RTA                                                 mAb (C110)                                                          Carcinoembryonic antigen (CEA)                                            Colon cancer                                                                                                                                                       Yes            Yes                                   \[536\]

  RTA                                         C19-RTA                                                      mAb (C19)                                                           Carcinoembryonic antigen (CEA)                                            Colorectal cancer                                                                                                                                                  Yes                                                  \[537\]

  RTA                                         M6-RTA                                                       mAb (M6)                                                            L2C IgM idiotype                                                          B-cell leukemia                                                                                                                                                    Yes            Yes                                   \[409\]

  RTA                                         38.13-RTA                                                    mAb (38.13)                                                         TH ceramide (Pk antigen)                                                  Burkitt\'s lymphoma                                                                                                                                                Yes                                                  \[324\]

  RTA                                         Fab\'-anti-L3T4-A                                            Fab\' (anti-L3T4)                                                   Murine T-cell antigen (limpet hemocyanin-specific T-helper lymphocytes)   Lymphoma                                                                                                                                                           Yes                                                  \[538\]

  RTA                                         486P-RTA                                                     mAb (486P 3-12-1)                                                   Bladder cancer antigen                                                    Bladder cancer                                                                                                                                                     Yes                                                  \[539\]

  RTA                                         RFT11-A                                                      mAb (RFT11)                                                         CD2                                                                       T-cell ALL                                                                                                                                                         Yes                                                  \[540\]

  RTA                                         35.1-A                                                       mAb (35.1)                                                          CD2                                                                       T-cell ALL                                                                                                                                                         Yes                                                  \[464, 540\]

  RTA                                         9.6-A                                                        mAb (9.6)                                                           CD2                                                                       T-cell ALL                                                                                                                                                         Yes                                                  \[464, 540\]

  RTA                                         10.2-A                                                       mAb (10.2)                                                          CD5                                                                       T cells                                                                                                                                                            Yes                                                  \[464\]

  RTA                                         452-D9-RTA                                                   mAb (452-D9)                                                        gp74                                                                      c-Ha-ras expression tumors, Kirsten sarcoma                                                                                                                        Yes            Yes                                   \[541, 542\]

  RTA                                         Thyroglobulin-RTA                                            Thyroglobulin                                                       Ig (anti-thyroglobulin)                                                   Thyroiditis                                                                                                                                                        Yes                                                  \[543\]

  RTA                                         96.5-RTA                                                     mAb (96.5)                                                          p97                                                                       Melanoma                                                                                                                                                           Yes                                                  \[544\]

  RTA                                         SN5d-RTA                                                     mAb (SN5d)                                                          CD10 (CALLA)                                                              Pre-B-cell ALL                                                                                                                                                     Yes            Yes                                   \[545\]

  RTA                                         SN5-RTA                                                      mAb (SN5)                                                           CD10 (CALLA)                                                              Pre-B-cell ALL                                                                                                                                                     Yes            Yes                                   \[545\]

  RTA                                         Anti-CALLA-RTA                                               mAb (anti-CALLA)                                                    CD10 (CALLA)                                                              Burkitt\'s lymphoma, (pre-B-cell ALL)                                                                                                                              Yes                                                  \[546\]

  RTA                                         Anti-CALLA-RTA                                               Fab\' (anti-CALLA)                                                  CD10 (CALLA)                                                              Burkitt\'s lymphoma, (pre-B-cell ALL)                                                                                                                              Yes                                                  \[546\]

  RTA                                         Anti-GE2-RTA                                                 mAb (anti-GE2)                                                      GE2                                                                       Glioma                                                                                                                                                             Yes                                                  \[410\]

  RTA                                         D1/12-RTA                                                    mAb (D1/12)                                                         HLA-DR                                                                    Glioma                                                                                                                                                             Yes                                                  \[410\]

  RTA                                         AR3-RTA                                                      mAb (AR3)                                                           CAR-3                                                                     Gastric cancer                                                                                                                                                     Yes                                                  \[411\]

  RTA                                         8C-RTA                                                       mAb (8C)                                                            Ovarian cancer antigen                                                    Ovarian cancer                                                                                                                                                     Yes            Yes                                   \[547\]

  RTA                                         M2A-RTA                                                      mAb (M2A)                                                           Ovarian cancer antigen                                                    Ovarian cancer                                                                                                                                                     Yes            Yes                                   \[547\]

  RTA                                         Anti-vasopressin-RTA                                         mAb (anti-vasopressin)                                              Vasopressin                                                               Pituitary cancer                                                                                                                                                   Yes            Yes                                   \[548\]

  RTA                                         Cluster 2 Mab-Fab\'-Anti-Mouse/RAT-RTA                       mAb (Cluster 2)                                                     Cluster 2 antigen-SCLC                                                    SCLC                                                                                                                                                               Yes                                                  \[549\]

  RTA                                         SOKT1-RTA                                                    mAb (SOKT1)                                                         T-cell antigen                                                            T cells                                                                                                                                                            Yes                                                  \[550\]

  RTA                                         MGb2-RTA                                                     mAb (MGb2)                                                          Gastric antigen                                                           Gastric cancer                                                                                                                                                     Yes                                                  \[551\]

  RTA                                         MG11-RTA                                                     mAb (MG11)                                                          Gastric antigen                                                           Gastric cancer                                                                                                                                                     Yes                                                  \[551\]

  RTA                                         MoAb-16-RTA                                                  mAb (16)                                                            Oncofetal antigen                                                         Leukemia                                                                                                                                                           Yes            Yes                                   \[368, 552\]

  RTA                                         Anti-laryngeal cancer-RTA                                    mAb (anti-laryngeal cancer)                                         Laryngeal cancer antigen                                                  Laryngeal cancer                                                                                                                                                   Yes                                                  \[553, 554\]

  RTA                                         317G5-RTA                                                    mAb (317G5)                                                         42 kDa glycoprotein (p42)                                                 Breast cancer                                                                                                                                                      Yes                                                  \[555\]

  RTA                                         SEN36-RTA                                                    mAb (SEN36)                                                         CD56 (N-CAM)                                                              SCLC                                                                                                                                                               Yes                                                  \[556\]

  RTA                                         Anti-mu-RTA                                                  mAb (anti-mu)                                                       Mu chain of IgM                                                           Myeloma                                                                                                                                                            Yes                                                  \[557\]

  RTA                                         SEN7-bR                                                      mAb (SEN7)                                                          CD56 (N-CAM)                                                              SCLC                                                                                                                                                               Yes                                                  \[558\]

  RTA                                         Anti-CRF-RTA                                                 mAb (anti-CRF)                                                      CRF (corticotropin-releasing factor)                                      Immunolesioning (CRF neurons within the paraventricular nucleus of the hypothalamus)                                                                                              Yes                                   \[559\]

  RTA                                         Anti-asialo-GM2-RTA                                          mAb (anti-asialo-GM2)                                               Asialo-GM2                                                                Lymphoma                                                                                                                                                           Yes                                                  \[560\]

  RTA                                         Anti-H-2d-RTA                                                mAb (anti-H-2d)                                                     H-2d                                                                      Lymphoma                                                                                                                                                           Yes                                                  \[560\]

  RTA                                         V beta 6-specific immunotoxin (VIT6)                         mAb (anti-V beta 6-specific)                                        V beta-associated antigen receptor                                        Myasthenia gravis                                                                                                                                                  Yes                                                  \[561\]

  RTA                                         schM21-ricin A                                               scFv (schM21)                                                       Astrocytoma- and medulloblastoma-associated antigen                       Medulloblastoma                                                                                                                                                    Yes                                                  \[562\]

  RTA                                         ONS-M21-RTA (ORA)                                            mAb (ONS-M21)                                                       Astrocytoma- and medulloblastoma-associated antigen                       Medulloblastoma                                                                                                                                                    Yes                                                  \[563\]

  RTA                                         Anti-VIP-RTA                                                 mAb (anti-VIP)                                                      Vasoactive intestinal polypeptide (VIP)                                   Pheochromocytoma, immunolesioning (neurons within the SCN) (suprachiasmatic nucleus of the hypothalamus)                                                           Yes            Yes                                   \[564\]

  RTA                                         Anti-Thy 1.2-RTA                                             IgG (anti-Thy 1.2)                                                  CD90.2 (Thy 1.2)                                                          Leukemia                                                                                                                                                           Yes            Yes                                   \[565\]

  RTA                                         IgE-ricin A-chain                                            mAb (IR162)                                                         IgE Fc receptor                                                           Allergies, basophil leukemia                                                                                                                                       Yes            Yes                                   \[566, 567\]

  RTA                                         OX-40-ricin A                                                mAb (anti-OX-40)                                                    OX-40                                                                     Autoimmune encephalomyelitis (EAE)                                                                                                                                 Yes            Yes                                   \[568\]

  RTA                                         SWA20-RTA                                                    mAb (SWA20)                                                         CD24                                                                      SCLC                                                                                                                                                               Yes                                                  \[467\]

  RTA                                         Anti-T. cruzi-RTA                                            IgG (anti-Trypanosoma cruzi surface antigens)                       Trypanosoma cruzi surface antigens                                        *Trypanosoma cruzi*                                                                                                                                                Yes            Yes                                   \[288\]

  RTA                                         UCHT1/F(ab\')2-ricin A chain                                 mAb (UCHT1) / F(ab\')2 (anti-IgG)                                   CD3                                                                       T-cell lymphoma                                                                                                                                                    Yes                                                  \[303\]

  RTA                                         RTA-NIM-R7                                                   mAb (NIM-R7)                                                        p58                                                                       Lymphoma                                                                                                                                                           Yes                                                  \[569\]

  Saporin                                     Anti-Thy 1.1 (F(ab\')2)-saporin                              F(ab\')2 (anti-Thy 1.1) (OX7)                                       CD90.1 (Thy 1.1)                                                          AKR-A lymphoma                                                                                                                                                     Yes            Yes                                   \[570\]

  Saporin                                     Anti-Thy 1.1 (mAb)-saporin                                   mAb (anti-Thy 1.1) (OX7)                                            CD90.1 (Thy 1.1)                                                          AKR-A lymphoma                                                                                                                                                     Yes            Yes                                   \[570\]

  Saporin                                     192 IgG-saporin (192-IgG-SAP) (IgG-192)                      mAb (192)                                                           Rat nerve growth factor receptor (p75NTR)                                 Immunolesioning (cholinergic basal forebrain neurons), Alzheimer\'s disease                                                                                        Yes            Yes                                   \[571-574\]

  Saporin                                     OM124-saporin                                                mAb (OM124)                                                         CD22                                                                      Burkitt\'s B-cell lymphoma, Epstein-Barr virus-infected B lymphoblastoid cells                                                                                     Yes            Yes                                   \[370\]

  Saporin                                     M24-saporin (anti-CD80/saporin)                              mAb (M24)                                                           CD80                                                                      Hodgkin\'s lymphoma, Burkitt\'s lymphoma                                                                                                                           Yes                                                  \[295\]

  Saporin                                     1G10-saporin (anti-CD86/saporin)                             mAb (1G10)                                                          CD86                                                                      Hodgkin\'s lymphoma, Burkitt\'s lymphoma                                                                                                                           Yes                                                  \[295\]

  Saporin                                     M24-saporin / 1G10-saporin                                   mAb (M24) / mAb (1G10)                                              CD80 + CD86                                                               Burkitt\'s lymphoma, Hodgkin\'s lymphoma                                                                                                                           Yes                                                  \[295\]

  Saporin                                     OKT11-saporin                                                mAb (OKT11)                                                         CD2                                                                       T-CLL                                                                                                                                                              Yes                                                  \[575, 576\]

  Saporin                                     7A10C9-saporin                                               mAb (7A10C9)                                                        CD2                                                                       T-CLL                                                                                                                                                              Yes                                                  \[575\]

  Saporin                                     OKT1-saporin                                                 OKT1                                                                CD5                                                                       T-lymphocytes, B-CLL                                                                                                                                               Yes            Yes                                   \[577-579\]

  Saporin                                     BsAb (HB2 x anti-saporin)/(OKT10 x anti-saporin)/saporin     Bispecific F(ab\')2 (HB2 x anti-saporin)/(OKT10 x anti-saporin)     CD7 + CD38                                                                T-ALL                                                                                                                                                              Yes                                                  \[580\]

  Saporin                                     BsAb (HB2 x anti-saporin)/saporin                            Bispecific F(ab\')2 (HB2 x anti-saporin)                            CD7                                                                       T-ALL                                                                                                                                                              Yes                                                  \[581\]

  Saporin                                     BsAb (OKT10 x anti-saporin)/saporin                          Bispecific F(ab\')2 (OKT10 x anti-saporin)                          CD38                                                                      T-ALL                                                                                                                                                              Yes                                                  \[580\]

  Saporin                                     HB2-saporin                                                  mAb (HB2)                                                           CD7                                                                       Lymphoma, T-ALL                                                                                                                                                    Yes            Yes                                   \[582-584\]

  Saporin                                     BU12-saporin                                                 mAb (BU12)                                                          CD19                                                                      B-LL, Burkitt\'s lymphoma                                                                                                                                          Yes            Yes                                   \[585-587\]

  Saporin                                     Rituximab/saporin-S6                                         mAb (rituximab)                                                     CD20                                                                      NHL                                                                                                                                                                Yes                                                  \[588\]

  Saporin                                     BsAb (4KB128 x anti-saporin)/saporin                         Bispecific F(ab\')2 (4KB128 x anti-saporin)                         CD22                                                                      Burkitt\'s lymphoma                                                                                                                                                Yes                                                  \[589\]

  Saporin                                     BsAb (HD37 x anti-saporin)/saporin                           Bispecific F(ab\')2 (4KB128 x anti-saporin)                         CD19                                                                      Burkitt\'s lymphoma                                                                                                                                                Yes                                                  \[589\]

  Saporin                                     BsAb (MB-1 x anti-saporin)/saporin                           Bispecific F(ab\')2 (4KB128 x anti-saporin)                         CD37                                                                      Burkitt\'s lymphoma                                                                                                                                                Yes                                                  \[589\]

  Saporin                                     BsAb (4KB128 x anti-saporin)/(RFB9 x anti-saporin)/saporin   Bispecific F(ab\')2 (4KB128 x anti-saporin)/(RFB9 x anti-saporin)   CD22                                                                      Lymphoma, CLL                                                                                                                                                      Yes            Yes           Phase I                 \[590\]

  Saporin                                     BsAb (4KB128 x anti-saporin)/(HD6 x anti-saporin)/saporin    Bispecific F(ab\')2 (4KB128 x anti-saporin)/(HD6 x anti-saporin)    CD22                                                                      B-cell lymphoma                                                                                                                                                    Yes            Yes           Phase I                 \[591\]

  Saporin                                     IB4/saporin-S6                                               mAb (IB4)                                                           CD38 (alpha-D-Galactopyranoside residues)                                 NHL                                                                                                                                                                Yes                                                  \[592\]

  Saporin                                     Anti-B7-1-saporin                                            mAb (B7-24)                                                         CD80                                                                      Burkitt\'s lymphoma, Hodgkin\'s lymphoma                                                                                                                           Yes                                                  \[593\]

  Saporin                                     Anti-CTLA-4 (83)-saporin (83-saporin)                        scFv (83)                                                           CD152 (Cytotoxic T-lymphocyte antigen-4, CTLA-4)                          Transplantation tolerance, leukemia, EBV-positive B-cell lymphoblastoid                                                                                            Yes            Yes                                   \[594-596\]

  Saporin                                     Anti-CTLA-4 (40)-saporin (40-saporin)                        scFv (40)                                                           CD152 (Cytotoxic T-lymphocyte antigen-4, CTLA-4)                          Transplantation tolerance, EBV-positive B-cell lymphoblastoid                                                                                                      Yes            Yes                                   \[594, 595\]

  Saporin                                     Anti-CTLA-4 (67)-saporin (67-saporin)                        scFv (67)                                                           CD152 (Cytotoxic T-lymphocyte antigen-4, CTLA-4)                          Transplantation tolerance, leukemia                                                                                                                                Yes                                                  \[596\]

  Saporin                                     ATG-saporin-S6                                               Antithymocyte globulin (ATG)                                        Thymocyte                                                                 Lymphoma, leukemia                                                                                                                                                 Yes                                                  \[597\]

  Saporin                                     HD6-saporin                                                  mAb (HD6)                                                           CD22                                                                      Lymphoma, B-CLL                                                                                                                                                    Yes                                                  \[598\]

  Saporin                                     HD39-saporin                                                 mAb (HD39)                                                          CD22                                                                      Lymphoma, B-CLL                                                                                                                                                    Yes                                                  \[598\]

  Saporin                                     HD37-saporin                                                 mAb (HD37)                                                          CD19                                                                      B-cell lymphoma                                                                                                                                                    Yes                                                  \[598\]

  Saporin                                     Saporin-EGF (SE)                                             EGF                                                                 EGFR                                                                      Breast cancer, sarcoma, adenocarcinoma, cervical cancer                                                                                                            Yes            Yes                                   \[599-602\]

  Saporin                                     SA2E                                                         EGF                                                                 EGFR                                                                      Breast cancer                                                                                                                                                      Yes            Yes                                   \[599-601\]

  Saporin                                     FGF-SAP                                                      FGF                                                                 FGFR                                                                      Melanoma, teratocarcinoma, neuroblastoma                                                                                                                           Yes            Yes                                   \[603\]

  Saporin                                     FGF2-SAP                                                     FGF-2                                                               FGFR                                                                      Bladder cancer                                                                                                                                                     Yes                                                  \[604\]

  Saporin                                     bFGF-saporin                                                 bFGF                                                                bFGFR                                                                     Prostate cancer                                                                                                                                                    Yes            Yes                                   \[605\]

  Saporin                                     ch25A11-Sap                                                  mAb (ch25A11)                                                       CUB domain-containing protein 1 (CDCP1)                                   Prostate cancer                                                                                                                                                    Yes            Yes                                   \[606\]

  Saporin                                     hJ591-saporin                                                mAb (hj591)                                                         Prostate-specific membrane antigen (PSMA)                                 Prostate cancer                                                                                                                                                    Yes            Yes                                   \[607\]

  Saporin                                     Ep2-saporin                                                  mAb (Ep2)                                                           Proteoglycan, p250                                                        Melanoma                                                                                                                                                           Yes                                                  \[608\]

  Saporin                                     ML30-saporin                                                 mAb (ML30)                                                          Heat shock protein 65 kDa (HSP65)                                         Leukemic monocyte lymphoma, pancreatic cancer                                                                                                                      Yes            Yes                                   \[609, 610\]

  Saporin                                     48-127/saporin-S6                                            mAb (48-127)                                                        gp54                                                                      Bladder cancer                                                                                                                                                     Yes                                                  \[379\]

  Saporin                                     Anti-ALCAM/CD166 scFv-saporin                                scFv (I/F8)                                                         CD166 (activated leukocyte cell adhesion molecule, ALCAM)                 SCLC, ovarian cancer                                                                                                                                               Yes                                                  \[611\]

  Saporin                                     7E4B11-saporin                                               mAb (7E4B11)                                                        RPTPβ                                                                     Astrocytic tumor, glioblastoma                                                                                                                                     Yes            Yes                                   \[612\]

  Saporin                                     Ber-H2-Saporin                                               mAb (Ber-H2)                                                        CD30                                                                      Hodgkin\'s lymphoma, anaplastic large-cell lymphoma(ALCL)                                                                                                          Yes            Yes           Phase I                 \[374, 613-616\]

  Saporin                                     Sap-ac-LDL                                                   Acetylated LDL                                                      Rat scavenger receptor                                                    Immunolesioning (microglia)                                                                                                                                        Yes                                                  \[617, 618\]

  Saporin                                     Anti-basigin-2-saporin                                       mAb (anti-basigin-2)                                                Human basigin-2 (CD147) (EMMPRIN)                                         Ovarian cancer                                                                                                                                                     Yes                                                  \[619\]

  Saporin                                     M290-SAP                                                     mAb (M290)                                                          CD103                                                                     Organ allograft rejection and GVHD                                                                                                                                 Yes            Yes                                   \[620\]

  Saporin                                     Anti-ChAT IgG-saporin                                        mAb (anti-ChAT)                                                     Choline acetyltransferase (ChAT)                                          Parkinson\'s and schizophrenia                                                                                                                                                    Yes                                   \[621-623\]

  Saporin                                     Anti-DAT-saporin                                             mAb (anti-DAT)                                                      Dopamine transporter (DAT)                                                Immunolesioning (dopaminergic neurons)                                                                                                                                            Yes                                   \[624\]

  Saporin                                     Anti-DBH-saporin                                             mAb (anti-DBH)                                                      Dopamine beta-hydroxylase (DBH)                                           Immunolesioning (noradrenergic neurons)                                                                                                                                           Yes                                   \[625-627\]

  Saporin                                     Anti-SERT-SAP                                                mAb (anti-SERT)                                                     Serotonin reuptake transporter (SERT)                                     Immunolesioning (serotonergic neurons)                                                                                                                             Yes            Yes                                   \[628\]

  Saporin                                     Bombesin-SAP                                                 Bombesin                                                            Gastrin-releasing peptide receptor (GRPR)                                 Immunolesioning (GRPR+ neurons)                                                                                                                                    Yes            Yes                                   \[629, 630\]

  Saporin                                     CCK-saporin                                                  CCK (cholecystokinin)                                               Cholecystokinin type 2 receptor (CCK2)                                    Immunolesioning (CCK+ neurons)                                                                                                                                                    Yes                                   \[631\]

  Saporin                                     CRF-SAP                                                      CRF (corticotropin-releasing factor)                                CRF receptor                                                              Immunolesioning (CRFR+ cells)                                                                                                                                      Yes            Yes                                   \[632, 633\]

  Saporin                                     CTB-SAP                                                      CTB (cholera toxin B-subunit)                                       GM1 ganglioside                                                           Immunolesioning (paraplegia)                                                                                                                                                      Yes                                   \[634\]

  Saporin                                     Dermorphin-saporin (MOR-SAP)                                 Dermorphin                                                          Mu opioid receptor (MOR)                                                  Immunolesioning (MOR+ neurons)                                                                                                                                                    Yes                                   \[631\]

  Saporin                                     Galanin-saporin (Gal-sap)                                    Galanin                                                             Galanin-1 receptor (GalR1)                                                Immunolesioning (GalR1+ neurons)                                                                                                                                                  Yes                                   \[635\]

  Saporin                                     GAT1-saporin                                                 IgG (GAT1)                                                          GABA-transporter-1                                                        Immunolesioning (MSDB neurons), Alzheimer\'s disease                                                                                                                              Yes                                   \[636\]

  Saporin                                     Lep-SAP                                                      Leptin                                                              Leptin receptor                                                           Immunolesioning (leptin receptor+ neuons)                                                                                                                                         Yes                                   \[637, 638\]

  Saporin                                     Anti-Mac-1-SAP                                               mAb (anti-Mac-1)                                                    CD11b (Mac-1)                                                             Immunolesioning (Mac-1+ neuons, microglia)                                                                                                                         Yes            Yes                                   \[639-642\]

  Saporin                                     ME20.4 IgG-saporin                                           mAb (ME20.4)                                                        Primate p75 low-affinity neurotrophin receptor (p75NTR)                   Immunolesioning (p75NTR+ neuons)                                                                                                                                                  Yes                                   \[643, 644\]

  Saporin                                     UF008/SAP                                                    IgG (UF008)                                                         Melanopsin                                                                Immunolesioning (intrinsically photosensitive retinal ganglion cells, ipRGCs)                                                                                      Yes            Yes                                   \[645, 646\]

  Saporin                                     NK3-SAP                                                      Neurokinin-3 (NK3)                                                  Neurokinin-3 receptor (NK3R)                                              Immunolesioning (NK3R+ neuons)                                                                                                                                                    Yes                                   \[647\]

  Saporin                                     NPY-SAP                                                      Neuropeptide Y (NPY)                                                Neuropeptide Y receptor (NPYR)                                            Immunolesioning (NPYR+ neuons)                                                                                                                                                    Yes                                   \[648, 649\]

  Saporin                                     OXY-SAP                                                      Oxytocin                                                            Oxytocin receptors (OXYR)                                                 Immunolesioning (OXYR+ neuons)                                                                                                                                     Yes            Yes                                   \[650\]

  Saporin                                     Substance P-saporin                                          Substance P                                                         Neurokinin-1 receptor (NK1R) (Substance P receptor)                       Immunolesioning (NK1R+ neurons), hyperalgesia                                                                                                                                     Yes                                   \[651-653\]

  Saporin                                     Hypocretin-saporin                                           Hypocretin (orexin)                                                 Hypocretin-2 receptor                                                     Narcolepsy (parvalbumin and cholinergic neurons)                                                                                                                                  Yes                                   \[654\]

  Saporin                                     TEC-T4-saporin                                               mAb (TEC-T4)                                                        CD4                                                                       T cells                                                                                                                                                            Yes                                                  \[655\]

  Saporin                                     MB-1 x anti-sap-1/saporin                                    Bispecific mAb (MB-1 x anti-sap-1)                                  CD37                                                                      Burkitt\'s lymphoma                                                                                                                                                Yes                                                  \[589\]

  Saporin                                     OKT10-saporin                                                mAb (OKT10)                                                         CD38                                                                      T-cell ALL, lymphocytes, macrophages                                                                                                                               Yes            Yes                                   \[584\]

  Saporin                                     Campath-1-saporin                                            mAb (Campath-1)                                                     CD52                                                                      GVHD, myeloid cells                                                                                                                                                Yes            Yes                                   \[656\]

  Saporin                                     TEC IgM-SAP                                                  mAb (TEC IgM)                                                       Immunoglobulin heavy chain                                                Burkitt's lymphoma                                                                                                                                                 Yes                                                  \[657\]

  Saporin                                     8A-saporin 6                                                 mAb (8A)                                                            8A plasma cell-associated antigens                                        Multiple myeloma, Burkitt's lymphoma                                                                                                                               Yes                                                  \[658\]

  Saporin                                     62B1-saporin                                                 mAb (62B1)                                                          62B1 plasma cell-associated antigens                                      Multiple myeloma, Burkitt's lymphoma                                                                                                                               Yes                                                  \[658\]

  Saporin                                     3BIT (BU12-saporin / OKT10-saporin + 4KB128-saporin)         mAb (BU12) / (OKT10) / (4KB128)                                     CD19 + CD22 + CD38                                                        Burkitt's lymphoma                                                                                                                                                 Yes            Yes                                   \[659\]

  Saporin                                     BU12-saporin / OKT10-saporin                                 mAb (BU12) / (OKT10)                                                CD19 + CD38                                                               Burkitt's lymphoma                                                                                                                                                 Yes            Yes                                   \[586\]

  Saporin                                     HB2-saporin / OKT10-saporin                                  mAb (HB2) / (OKT10)                                                 CD7 + CD38                                                                T-cell ALL                                                                                                                                                         Yes            Yes                                   \[584\]

  Saporin                                     B3/25-SO6                                                    mAb (B3/25)                                                         TfR                                                                       Leukemia                                                                                                                                                           Yes                                                  \[660\]

  Saporin                                     LAM3/saporin                                                 mAb (LAM3)                                                          M5b leukemia antigen                                                      Acute non-lymphoid leukemia (ANLL)                                                                                                                                 Yes                                                  \[610, 661\]

  Saporin                                     Tf-saporin                                                   Transferrin                                                         TfR                                                                       Prostate cancer                                                                                                                                                    Yes                                                  \[529\]

  Saporin                                     uPA-SAP                                                      uPAcs (urokinase-type plasminogen activator)                        Urokinase receptor                                                        Lymphoma                                                                                                                                                           Yes                                                  \[662\]

  Saporin                                     11A8-saporin                                                 mAb (11A8)                                                          bFGFR                                                                     Ovarian cancer                                                                                                                                                     Yes            Yes                                   \[663\]

  Saporin                                     Anti-CD8-saporin                                             mAb (anti-CD8)                                                      CD8                                                                       T-cell lymphoma                                                                                                                                                    Yes                                                  \[655\]

  Saporin                                     HBEGF-saporin                                                HB-EGF                                                              EGFR                                                                      Breast cancer, bladder cancer, melanoma, leukemia, colon cancer, renal cancer, ovarian cancer, prostate cancer, non-small cell lung cancer (NSCLC), brain cancer   Yes                                                  \[664\]

  Saporin                                     HBEGF-L22-saporin                                            HB-EGF                                                              EGFR                                                                      Breast cancer, bladder cancer, melanoma, leukemia, colon cancer, renal cancer, ovarian cancer, prostate cancer, non-small cell lung cancer (NSCLC), brain cancer   Yes            Yes                                   \[664\]

  Saporin                                     B-B10-saporin                                                mAb (B-B10)                                                         CD25 (IL-2 receptor)                                                      GVHD                                                                                                                                                               Yes                                                  \[665\]

  Saporin                                     W6/800E6-SAP                                                 mAb (W6/800E6)                                                      HER2                                                                      Breast cancer                                                                                                                                                      Yes                                                  \[666\]

  Saporin                                     W6/900H1-SAP                                                 mAb (W6/900H1)                                                      HER2                                                                      Breast cancer                                                                                                                                                      Yes                                                  \[666\]

  Saporin                                     H2-Dd-saporin                                                H2-Dd MHC class I tetramer                                          T-cell receptor (TCR)                                                     diabetes mellitus, CD8+ T cells                                                                                                                                    Yes                                                  \[667\]

  Saporin                                     2F8-saporin                                                  mAb (2F8)                                                           CD163 (SR-A)                                                              Ovarian cancer                                                                                                                                                     Yes            Yes                                   \[668\]

  Saporin                                     Insulin-saporin (saporin insulin complex, SIC)               Insulin                                                             Insulin receptor                                                          Ovarian cancer, hepatocellular carcinoma                                                                                                                           Yes                                                  \[669\]

  Saporin                                     B-B2-saporin                                                 mAb (BB2)                                                           Myeloma antigen                                                           Multiple myeloma                                                                                                                                                   Yes                                                  \[670\]

  Saporin                                     B-B4-saporin                                                 mAb (BB4)                                                           Myeloma antigen                                                           Multiple myeloma                                                                                                                                                   Yes                                                  \[670\]

  Saporin                                     Anti-epithelial antigen-saporin 6                            mAb (anti-epithelial antigen)                                       Epithelial antigen                                                        Colon cancer, epidermoid carcinoma                                                                                                                                 Yes                                                  \[302\]

  Saporin                                     Anti-SA-1-saporin                                            mAb (anti-SA-1)                                                     mAb (SA-1) (16/6 idiotype binding to DNA)                                 Systemic lupus erythematosus (SLE)                                                                                                                                 Yes            Yes                                   \[671\]

  Saporin                                     Anti-Id-saporin                                              mAb (anti-Id)                                                       mAb (Anti-Id) (anti-lymphoma idiotype)                                    B-cell leukemia                                                                                                                                                    Yes            Yes                                   \[672\]

  Saporin                                     HB6-1 x anti-sap-1/saporin                                   Bispecific mAb (HB6-1 x anti-sap-1)                                 κ-chain                                                                   Burkitt\'s lymphoma                                                                                                                                                Yes                                                  \[589\]

  Saporin                                     M15-8 x anti-sap-1/saporin                                   Bispecific mAb (M15-8 x anti-sap-1)                                 µ-chain                                                                   Burkitt\'s lymphoma                                                                                                                                                Yes                                                  \[589\]

  Saporin                                     RFB-9 x anti-sap-1/saporin                                   Bispecific mAb (RFB-9 x anti-sap-1)                                 CD19                                                                      Burkitt\'s lymphoma                                                                                                                                                Yes                                                  \[589\]

  Saporin                                     WR17 x anti-sap-1/saporin                                    Bispecific mAb (WR17 x anti-sap-1)                                  CD37                                                                      Burkitt\'s lymphoma                                                                                                                                                Yes                                                  \[589\]

  Saporin                                     LAM7/saporin                                                 mAb (LAM7)                                                          M5b leukemia antigen                                                      Acute non-lymphoid leukemia (ANLL)                                                                                                                                 Yes                                                  \[610, 661\]

  Saporin                                     62B8-saporin 6                                               mAb (62B8)                                                          62B8 myeloma antigen                                                      Multiple myeloma                                                                                                                                                   Yes                                                  \[658\]

  Saporin                                     F(ab\')2-saporin/UCHT1                                       F(ab\')2 (anti-IgG) / mAb (UCHT1)                                   CD3                                                                       T-cell lymphoma                                                                                                                                                    Yes                                                  \[303\]

  Saporin                                     F(ab\')2-saporin/anti-CD2                                    F(ab\')2 (anti-IgG) / mAb (anti-CD2)                                CD2                                                                       T-cell lymphoma                                                                                                                                                    Yes                                                  \[303\]

  Saporin                                     F(ab\')2-saporin/anti-CD5                                    F(ab\')2 (anti-IgG) / mAb (anti-CD5)                                CD5                                                                       T-cell lymphoma                                                                                                                                                    Yes                                                  \[303\]

  Saporin                                     F(ab\')2-saporin/C11                                         F(ab\')2 (anti-IgG) / mAb (C11)                                     CD45                                                                      Hodgkin\'s lymphoma                                                                                                                                                Yes                                                  \[303\]

  Saporin                                     F(ab\')2-saporin/TEC-T4                                      F(ab\')2 (anti-IgG) / mAb (TEC-T4)                                  CD4                                                                       T-cell lymphoma                                                                                                                                                    Yes                                                  \[303\]

  Saporin                                     F(ab\')2-saporin/HSR-3                                       F(ab\')2 (anti-IgG) / mAb (HSR-3)                                   CD30                                                                      Hodgkin\'s lymphoma                                                                                                                                                Yes                                                  \[303\]

  Saporin                                     F(ab\')2-saporin/8A                                          F(ab\')2 (anti-IgG) / mAb (8A)                                      8A myeloma antigen                                                        Burkitt lymphoma, multiple myeloma                                                                                                                                 Yes                                                  \[303\]

  Saporin                                     F(ab\')2-saporin/62B1                                        F(ab\')2 (anti-IgG) / mAb (62B1)                                    62B1 myeloma antigen                                                      Multiple myeloma                                                                                                                                                   Yes                                                  \[303\]

  Saporin                                     PlGF-2-saporin                                               Placental growth factor-2 (PlGF-2)                                  PlGF-2 receptor                                                           Tumor neovascularization                                                                                                                                           Yes                                                  \[673\]

  Saporin                                     ATF-saporin                                                  ATF (amino-terminal fragment of human urokinase)                    Urokinase receptor                                                        Metastasis                                                                                                                                                         Yes                                                  \[674\]

  Saporin                                     Cetuximab-saporin                                            mAb (cetuximab)                                                     EGFR                                                                      Colorectal cancer, prostate cancer, epidermoid carcinoma, breast cancer                                                                                            Yes                                                  \[675, 676\]

  Saporin                                     Trastuzumab-saporin                                          mAb (trastuzumab)                                                   HER2                                                                      Breast cancer                                                                                                                                                      Yes                                                  \[676, 677\]

  Saporin                                     2H8/anti-GAM IgG-saporin                                     mAb (2H8) / IgG (anti-GAM IgG)                                      Tomoregulin                                                               Prostate cancer                                                                                                                                                    Yes                                                  \[678\]

  Saporin                                     By114/anti-IgG-saporin                                       mAb (By114) / IgG (anti-IgG)                                        Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6)       Pancreatic cancer                                                                                                                                                  Yes            Yes                                   \[679\]

  Saporin                                     6-22 IgG/anti-GAH IgG-saporin                                mAb (6-22 IgG) / IgG (anti-GAH IgG)                                 Human aspartyl (asparaginyl) β-hydroxylase (HAAH)                         Hepatocellular carcinoma                                                                                                                                           Yes                                                  \[680\]

  Saporin                                     Anti-endosialin/anti-IgG-saporin                             mAb (anti-endosialin) / IgG (anti-IgG)                              Endosialin (CD248, tumor endothelial marker 1, TEM1)                      Ewing\'s sarcoma, neuroblastoma                                                                                                                                    Yes                                                  \[681\]

  Saporin                                     Anti-TCblR-saporin                                           mAb (anti-TCblR)                                                    CD320 (transcobalamin receptor, TCblR)                                    CML, colon cancer                                                                                                                                                  Yes                                                  \[682\]

  Saporin                                     AF334-saporin                                                mAb (AF334)                                                         Tumor endothelial marker 8 (TEM8)                                         Tumor neovascularization                                                                                                                                           Yes                                                  \[683\]

  Saporin                                     MRK16/anti-IgG-saporin                                       mAb (MRK16) / IgG (anti-IgG)                                        170 kDa glycoprotein (gp170)                                              Colon cancer                                                                                                                                                       Yes                                                  \[684\]

  Trichokirin                                 AT15E-TKR (AT15E-Trichokirin)                                mAb (anti-Thy 1.2) (AT15E)                                          CD90.2 (Thy 1.2)                                                          Leukemia                                                                                                                                                           Yes            Yes                                   \[270\]

  Trichokirin                                 F(ab\')2-trichokirin/UCHT1                                   F(ab\')2 (anti-IgG) / mAb (UCHT1)                                   CD3                                                                       T-cell lymphoma                                                                                                                                                    Yes                                                  \[303\]

  Trichosanthin                               TCS-Hepama-1 (Hepama-1-trichosanthin)                        mAb (Hepama-1)                                                      Hepatoma-associated antigen 43 kDa glycoprotein                           Hepatoma                                                                                                                                                           Yes            Yes                                   \[685, 686\]

  Trichosanthin                               p75-TCS (anti-p75-anti-mouse IgG-trichosanthin)              mAb (192) / IgG (anti-mouse)                                        Rat nerve growth factor (NGF) receptor (p75 receptor) (p75NTR)            Immunolesioning (cholinergic basal forebrain neurons)                                                                                                              Yes                                                  \[574\]

  Trichosanthin                               CMU15---TCS                                                  mAb (CMU15A)                                                        Lung cancer antigen                                                       Lung cancer                                                                                                                                                        Yes            Yes                                   \[687, 688\]

  Trichosanthin                               TCS-Ng76                                                     mAb (Ng76)                                                          Melanoma antigen                                                          Melanoma                                                                                                                                                           Yes                                                  \[689\]

  Trichosanthin                               EGF-TCS                                                      EGF                                                                 EGFR                                                                      Hepatocellular carcinoma                                                                                                                                           Yes            Yes                                   \[690, 691\]

  Trichosanthin                               EGF-TCSredlk                                                 EGF                                                                 EGFR                                                                      Hepatocellular carcinoma                                                                                                                                           Yes            Yes                                   \[692\]
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

A detailed list of all the efficacy enhancers employed in the improvement of toxin efficacy and enhancement of endosomal escape.

  Efficacy Enhancers                                               Origin                                                                     Factor                     Site of Action                                                Application                                                            Ref.
  ---------------------------------------------------------------- -------------------------------------------------------------------------- -------------------------- ------------------------------------------------------------- ---------------------------------------------------------------------- -------------------
  *Lysosomotropic amines*                                                                                                                                                                                                                                                                                     
  Ammonium chloride                                                Inorganic                                                                  6700                       Endosomes                                                     Immunotoxins (RTA)                                                     \[693, 694\]
  Methylamine                                                      Organic                                                                    13,300                     Endosomes                                                     Immunotoxins (RTA)                                                     \[693\]
  Dimethylamine                                                    Organic                                                                    3300                       Endosomes                                                     Immunotoxins (RTA)                                                     \[693\]
  Trimethylamine                                                   Organic                                                                    80                         Endosomes                                                     Immunotoxins (RTA)                                                     \[693\]
  Amantadine                                                       Organic                                                                    1180                       Endosomes                                                     Immunotoxins (RTA)                                                     \[693, 695\]
  Chloroquine                                                      Organic                                                                    2500                       Endosomes                                                     Immunotoxins (RTA, Gel)                                                \[693, 696\]
  Lipopolyamines                                                   Organic                                                                    10 - 250                   Endosomes                                                     Immunotoxins (Sap)                                                     \[697\]
  β-Glycylphenyl-naphthylamide (GPN)                               Organic                                                                    10                         Endosomes                                                     Immunotoxins (PE)                                                      \[698\]
  Quinacrine                                                       Organic                                                                    15                         Endosomes                                                     immunotoxins (Gel)                                                     \[696\]
  *Carboxylic ionophores*                                                                                                                                                                                                                                                                                     
  Monensin                                                         Organic                                                                    50,000                     Lysosomes                                                     Immunotoxins (RTA, Gel)                                                \[693, 696, 699\]
  Grisorixin                                                       Organic                                                                    25,000                     Lysosomes                                                     Immunotoxins (RTA)                                                     \[693\]
  Lasalocid                                                        Organic                                                                    33,000                     Lysosomes                                                     Immunotoxins (RTA)                                                     \[693\]
  Nigericin                                                        Organic                                                                    6700                       Lysosomes                                                     Immunotoxins (RTA)                                                     \[693\]
  *Calcium channel antagonists*                                                                                                                                                                                                                                                                               
  Verapamil                                                        Organic                                                                    170                        Lysosomes or other vesicular compartments                     Immunotoxins (RTA, PE, Gel)                                            \[696, 698, 700\]
  Diltiazem                                                        Organic                                                                    10, 40                     Lysosomes or other vesicular compartments                     Immunotoxins (PE)                                                      \[698\]
  Methoxyverapamil (D-600)                                         Organic                                                                    40                         Lysosomes or other vesicular compartments                     Immunotoxins (PE)                                                      \[698\]
  Varapamil analogues                                              Organic                                                                    2 - 70                     Lysosomes or other vesicular compartments                     Immunotoxins (RTA, PE)                                                 \[700\]
  Perhexiline                                                      Organic                                                                    10 - 2000                  Lysosomes or other vesicular compartments                     Immunotoxins (RTA)                                                     \[701\]
  SR 33557                                                         Organic                                                                    540                        Lysosomes or other vesicular compartments                     Immunotoxins (RTA)                                                     \[702\]
  SR 33287                                                         Organic                                                                    620                        Lysosomes or other vesicular compartments                     Immunotoxins (RTA)                                                     \[702\]
  *Organic polymers*                                                                                                                                                                                                                                                                                          
  Polyethylenimine (PEI)                                           Organic polymer                                                            From no-effect to effect   Lysosomes                                                     Gene transfection                                                      \[703\]
  Poly(amidoamine)s (PAAs)                                         Organic polymer                                                            100                        Endosomes and lysosomes                                       Toxins (RTA, Gel, Sap), Gene delivery                                  \[704-706\]
  Poly(propylacrylic acid) (PAAP)                                  Organic polymer                                                            Significant increase       Endosomes                                                     Gene transfection                                                      \[707\]
  *Fusogenic lipids*                                                                                                                                                                                                                                                                                          
  DOPE                                                             Organic                                                                    Significant increase       Endosomes                                                     Gene transfection, liposomes                                           \[708\]
  CHEMS                                                            Organic                                                                    Significant increase       Endosomes                                                     siRNA delivery                                                         \[709\]
  Monoolein                                                        Organic                                                                    Significant increase       Endosomes                                                     DNA delivery, nanoparticles                                            \[75\]
  *Other organic compounds*                                                                                                                                                                                                                                                                                   
  Retinoic acid                                                    Organic                                                                    10,000                     Golgi apparatus                                               Immunotoxins (RTA)                                                     \[710\]
  Cyclosporin A                                                    Organic                                                                    100                        Vesicular compartments                                        Immunotoxins (RTA)                                                     \[711, 712\]
  Brefeldin-A                                                      Organic                                                                    1000                       Golgi apparatus                                               Immunotoxins (RTA)                                                     \[713\]
  Bryostatin 1                                                     Organic                                                                    Significant increase       Cell signalling                                               Immunotoxins (PE)                                                      \[714\]
  Wortmannin                                                       Organic                                                                    Significant increase       Endosomes and lysosomes                                       Immunotoxins (ETA, Sap, Gel)                                           \[715\]
  Synthetic surfactants                                            Organic                                                                    Significant increase       Endosomes                                                     Gene transfection, siRNA delivery, nanoparticles                       \[716, 717\]
  EHCO                                                             Organic                                                                    Significant increase       Endosomes                                                     siRNA delivery, nanoparticles                                          \[718\]
  *Viruses and virus peptides*                                                                                                                                                                                                                                                                                
  Adenovirus                                                       Adenovirus                                                                 10,000                     Endosomes, lysosomes or other vesicular compartments          Immunotoxins (PE, RTA, Sap, Gel), gene delivery                        \[719-721\]
  Penton base protein (adenovirus capsid protein)                  Adenovirus                                                                 100                        Endosomes and lysosomes                                       Immunotoxins (PE, Gel)                                                 \[722, 723\]
  Minor capsid protein VI                                          Adenovirus                                                                 From no-effect to effect   Endosomes                                                     Nanoparticles                                                          \[724, 725\]
  KFT25 (N-terminus of Protein G)                                  Vesicular stomatitis virus                                                 10 - 20                    Lysosomes or other vesicular compartments                     Immunotoxins (RTA, Dia)                                                \[309, 528\]
  HA2 (hemagglutinin HA-2)                                         Influenza virus                                                            10 - 100                   Endosomes                                                     Immunotoxins (RTA, Sap), gene transfer                                 \[82, 726, 727\]
  HA2 / poly (L-lysine) (PLL)                                      Influenza virus                                                            Significant increase       Endosomes                                                     Gene transfer                                                          \[728\]
  HA23                                                             Influenza virus                                                            4 - 5                      Endosomes                                                     Immunotoxins (RTA)                                                     \[729\]
  GALA                                                             Synthetic peptide (HIV)                                                    From no-effect to effect   Endosomes                                                     Gene transfection, liposomes, nanoparticles                            \[726, 730, 731\]
  KALA                                                             Synthetic peptide (HIV)                                                    From no-effect to effect   Endosomes and other membranes                                 Gene transfection                                                      \[732\]
  KALA/polyethylenimine (PEI)                                      Synthetic peptide (HIV)                                                    Significant increase       Endosomes and other membranes                                 Gene transfection                                                      \[733, 734\]
  INF-7                                                            Influenza virus                                                            100                        Endosomes                                                     Gene delivery, siRNA delivery, liposomes                               \[735-737\]
  Tat (transcriptional activator Tat protein)                      HIV                                                                        3340                       Endosomes                                                     DNA delivery, PNA delivery, liposomes, nanoparticles                   \[738-740\]
  gp41                                                             HIV                                                                        Significant increase       Endosomes                                                     Gene delivery, siRNA delivery                                          \[741\]
  gp41/polyethylenimine (PEI)                                      HIV                                                                        Significant increase       Endosomes                                                     Gene delivery, siRNA delivery                                          \[742\]
  L2 (minor capsid protein)                                        Papillomavirus                                                             From no-effect to effect   Endosomes and other membranes                                 Proteins (GFP)                                                         \[743\]
  Major envelope protein (E)                                       West Nile virus                                                            From no-effect to effect   Endosomes                                                     Natural process                                                        \[744\]
  VP22 (structural protein VP22)                                   Herpes simplex virus                                                       From no-effect to effect   Actin-mediated endosomes                                      DNA delivery, proteins (GFP)                                           \[729\]
  Synthetic analogue of glycoprotein H (gpH)                       Synthetic peptide (Herpes simplex virus)                                   30                         Endosomes                                                     Gene transfection, liposomes                                           \[745\]
  PreS2-domain of hepatitis-B virus surface antigen (TLM)          Hepatitis-B virus                                                          2 - 20                     Endosomes or other vesicular compartments                     Immunotoxins (Sap, Ang)                                                \[600, 746, 747\]
  *Bacterial peptides*                                                                                                                                                                                                                                                                                        
  Listeriolysin O (LLO)                                            *Listeria* *monocytogenes*                                                 Significant increase       Endosomes                                                     DNA delivery, liposomes                                                \[748, 749\]
  Pneumococcal pneumolysin (PLO)                                   Pneumococcos                                                               From no-effect to effect   Endosomes                                                     Toxins (Granzyme B)                                                    \[750\]
  Streptococcal streptolysin O (SLO)                               Streptococcos                                                              From no-effect to effect   Endosomes                                                     Toxins (Granzyme B)                                                    \[750\]
  T-domain of diphtheriatoxin (DT)                                 *Corynebacterium diphtheria*                                               From no-effect to effect   Endosomes                                                     Immunotoxins (DT)                                                      \[751\]
  T-domain of diphtheria toxin (DT) / poly(ethylenimine) (PEI)     *Corynebacterium diphtheria*                                               Significant increase       Endosomes                                                     Gene transfection                                                      \[752\]
  Domain II of *Pseudomonas* exotoxin A (ETA)                      *Pseudomonas aeruginosa*                                                   From no-effect to effect   Endosomes and *trans*-Golgi network                           Immunotoxins (PE)                                                      \[753\]
  REDLK                                                            *Pseudomonas aeruginosa*                                                   From no-effect to effect   Endoplasmatic reticulum                                       Immunotoxins (PE)                                                      \[754\]
  *Animal and human peptides*                                                                                                                                                                                                                                                                                 
  Penetratin (homeotic transcription protein Antennapedia, Antp)   *Drosophila melanogaster*                                                  From no-effect to effect   Pinocytic and other vesicular compartments                    PNA delivery                                                           \[755\]
  R6-Penetratin (with arginine residues)                           Synthetic (*Drosophila melanogaster*)                                      5 - 10                     Endosmes and other vesicular compartments                     PNA delivery                                                           \[756\]
  EB1 (synthetic analog of penetratin)                             Synthetic (*Drosophila melanogaster*)                                      Significant increase       Endosomes                                                     siRNA delivery                                                         \[757\]
  hCT (9-32) (human calcitonin derived peptide 9-32)               Human                                                                      From no-effect to effect   Endosomes or other vesicular compartments                     Natural process                                                        \[758, 759\]
  Fibroblast growth factor-1 (FGF-1) sequence                      Human                                                                      From no-effect to effect   Endosomes                                                     Natural process                                                        \[760\]
  Melittin                                                         Bee venom                                                                  From no-effect to effect   Endosomes                                                     Gene delivery                                                          \[726, 761\]
  Melittin/polyethylenimine (PEI)                                  Bee venom                                                                  Significant increase       Endosomes                                                     Gene delivery, siRNA delivery                                          \[762-764\]
  Human β3 integrin signal sequence                                Human                                                                      From no-effect to effect   Endosomes                                                     Natural process                                                        \[765\]
  Heavy chain of immunoglobulin G                                  *Caiman crocodylus*                                                        Significant increase       Cell membrane                                                 Liposomes                                                              \[766\]
  Transportan                                                      Synthetic peptide (neuropeptide galanin + wasp venom peptide mastoparan)   From no-effect to effect   Endosomes or other vesicular compartments                     Proteins (GFP, Strep)                                                  \[767\]
  Bovine prion protein (bPrPp)                                     Synthetic peptide (bobine prion)                                           From no-effect to effect   Cell membrane, macropinosomes                                 Nanoparticles                                                          \[768, 769\]
  KDEL                                                             Signal sequence                                                            100 - 1000                 Endoplasmatic reticulum                                       Immunotoxins (RTA, PE)                                                 \[770, 771\]
  *Animal and human proteins*                                                                                                                                                                                                                                                                                 
  α-Interferon (INF)                                               Human                                                                      Significant increase       Cell signalling                                               Immunotoxins (RTA)                                                     \[772\]
  Perforin                                                         Human                                                                      From no-effect to effect   Early endosomes                                               Immunotoxins (GzmB)                                                    \[773, 774\]
  Rituximab                                                        Mouse/human chimeric mAb                                                   80                         Cell signalling                                               Immunotoxins (Sap)                                                     \[587\]
  *Plant saponins*                                                                                                                                                                                                                                                                                            
  *Saponinum album*                                                *Gypsophila paniculata*L.                                                  2,500,000                  Late endosomes and lysosomes                                  Immunotoxins (Sap)                                                     \[599, 775, 776\]
  SA-1641                                                          *Gypsophila paniculata*L.                                                  Significant increase       Late endosomes and lysosomes                                  Immunotoxins (Sap, Dia)                                                \[83, 84\]
  SA-1657                                                          *Gypsophila paniculata*L.                                                  From no-effect to effect   Late endosomes and lysosomes                                  Immunotoxins (Sap)                                                     \[52\]
  *Saponaria*saponins                                              *Saponaria officinalis* L.                                                 10, 000                    Late endosomes and lysosomes                                  Immunotoxins (Sap)                                                     \[52\]
  SO-1861                                                          *Saponaria officinalis*L.                                                  1000                       Late endosomes and lysosomes                                  Immunotoxins (Sap, Dia)                                                \[52\]
  *Quillaja*saponins                                               *Quillaja saponaria* Mol.                                                  1400                       Late endosomes and lysosomes                                  Immunotoxins (Sap)                                                     \[775\]
  *Plant proteins*                                                                                                                                                                                                                                                                                            
  Ricin B-chain                                                    *Ricinus communis* L.                                                      From no-effect to effect   Interalization/Cell signalling                                Immunotoxins (RTA)                                                     \[777\]
  Ricin B-chain immunotoxin                                        *Ricinus communis* L.                                                      2 - 4                      Interalization/Cell signalling                                Immunotoxins (RTA)                                                     \[778\]
  Ricin B chain (piggyback)                                        *Ricinus communis* L.                                                      2 - 6                      Interalization/Cell signalling                                Immunotoxins (RTA)                                                     \[779\]
  *Synthetic peptides*                                                                                                                                                                                                                                                                                        
  Polyarginines                                                    Synthetic peptide                                                          Significant increase       Late endosomes, Golgi apparatus and endoplasmatic reticulum   DNA delivery, siRNA delivery, proteins (GFP)                           \[780-782\]
  Polylysines                                                      Synthetic peptide                                                          Significant increase       Endosomes                                                     Gene transfection                                                      \[783\]
  Histidine 10                                                     Synthetic peptide                                                          7000                       Endosomes                                                     Gene transfection                                                      \[784\]
  (R-Ahx-R)4                                                       Synthetic peptide                                                          From no-effect to effect   Late endosomes, Golgi apparatus and endoplasmatic reticulum   PNA delivery                                                           \[74, 785\]
  Poly(L-histidine)                                                Synthetic peptide                                                          Significant increase       Endosomes                                                     DNA delivery                                                           \[786, 787\]
  Sweet arrow peptide (SAP)                                        Synthetic peptide                                                          Significant increase       Endosomes                                                     Gene delivery, nanoparticles                                           \[788\]
  Loligomer                                                        Synthetic peptide                                                          From no-effect to effect   Endosomes or other vesicular compartments                     Peptide delivery, fluorescent probes                                   \[789\]
  Amphiphilic model peptide                                        Synthetic peptide                                                          From no-effect to effect   Endosomes or other vesicular compartments                     Polar bioactive compounds                                              \[790\]
  IRQ peptide                                                      Synthetic peptide                                                          Significant increase       Endosomes                                                     siRNA delivery                                                         \[709\]
  43E peptide                                                      Synthetic peptide                                                          Significant increase       Endosomes and lysosomes                                       Gene transfection                                                      \[791\]
  pJVE                                                             Synthetic peptide                                                          2                          Endosomes                                                     Immunotoxins (Dia)                                                     \[309\]
  RAWA                                                             Synthetic peptide                                                          Significant increase       Endosomes and other membranes                                 Gene delivery                                                          \[792\]
  Nuclear localization signals                                     Synthetic peptide                                                          150                        Cytoplasmic entrapment, nuclear membrane                      Gene transfection                                                      \[793\]
  SynB1                                                            Synthetic peptide                                                          6                          Endosomes and other membranes                                 Peptide delivery                                                       \[78, 794\]
  Pep-1                                                            Synthetic peptide                                                          From no-effect to effect   Endosomes and other membranes                                 Peptide delivery, proteins (GFP, β-Gal)                                \[795\]
  *Physicochemical techniques*                                                                                                                                                                                                                                                                                
  Photochemical internalization                                    Technique                                                                  1000                       Endosomes                                                     Immunotoxins (Sap, Gel), gene transfection, liposomes, nanoparticles   \[796-798\]
  Ultrasound                                                       Technique                                                                  30                         Endosomes                                                     Gene delivery, liposomes                                               \[799, 800\]
  Plasmonic nanobubbles                                            Technique                                                                  30                         Endosomes                                                     Nanoparticles                                                          \[801\]
  Magnetic nanoparticles                                           Technique                                                                  From no-effect to effect   Endosomes                                                     Gene transfection, siRNA delivery, nanoparticles                       \[76, 802\]
